EXPLORING THE MECHANISM OF ALGINATE ACETYLATION IN PSEUDOMONAS AERUGINOSA by Paletta, Janice
Virginia Commonwealth University 
VCU Scholars Compass 
Theses and Dissertations Graduate School 
2010 
EXPLORING THE MECHANISM OF ALGINATE ACETYLATION IN 
PSEUDOMONAS AERUGINOSA 
Janice Paletta 
Virginia Commonwealth University 
Follow this and additional works at: https://scholarscompass.vcu.edu/etd 
 Part of the Medicine and Health Sciences Commons 
 
© The Author 
Downloaded from 
https://scholarscompass.vcu.edu/etd/62 
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It 
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars 
Compass. For more information, please contact libcompass@vcu.edu. 
 
 
 
 
 
 
 
 
 
 
 
© Janice L. Paletta 2010 
All Rights Reserved 
  
 
 
EXPLORING THE MECHANISM OF ALGINATE ACETYLATION IN PSEUDOMONAS 
AERUGINOSA 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University 
 
 
 
 
By 
 
 
 
 
Janice L. Paletta 
Bachelor of Science, Virginia Commonwealth University, May 1993 
 
 
 
Director:  Dennis E. Ohman, Ph.D. 
Chairman, Department of Microbiology and Immunology 
 
 
 
 
 
 
 
 
 
Virginia Commonwealth University 
Richmond, Virginia 
April 2010 
 
  
i 
 
Dedication 
 With deepest gratitude to my family and friends.  Without their love, patience, and 
support this work would not have been possible. 
  
ii 
 
Acknowledgements 
I would like to thank Dr. Dennis E. Ohman for allowing me the opportunity to work in his 
lab over the last several years.  It has been a very enriching experience and I know that what I 
have learned while working in his laboratory will continue to be of great benefit to me 
throughout my career.  I would also like to thank the members of my graduate committee; Dr. J. 
F. Chlebowski, Dr. W. M. Holmes, Dr. P. B. Hylemon, and Dr. T. O. Kitten, for their guidance 
during this project. 
 Many thanks are due Eric Fleming, friend and former lab member, for his support during 
this endeavor. 
 I am especially grateful to Jean Kim, friend and lab member.  Her support and friendship 
since the very beginning of the graduate program have allowed me to successfully accomplish 
my goals.  This work would not have been possible without the benefit of our frequent technical 
discussions and her unfailing and unwavering support.  
 I would also like to thank Dr. Ohman and the department of Microbiology and 
Immunology for their financial support, without which this work would not have been possible.  
iii 
 
Table of Contents 
Acknowledgements ......................................................................................................................... ii 
List of Tables ................................................................................................................................. vi 
List of Figures ............................................................................................................................... vii 
Abstract ........................................................................................................................................... x 
Section 
1  Introduction ............................................................................................................... 1 
The genus Pseudomonas ................................................................................... 1 
P. aeruginosa and the cystic fibrosis lung ........................................................ 2 
Alginate biosynthesis operon ............................................................................ 3 
Regulation of alginate biosynthesis in Pseudomonas aeruginosa .................... 8 
Regulation of alginate biosynthesis in Azotobacter vinelandii ......................... 9 
Alginate acetylation and opsonization ............................................................ 10 
Research Objectives ........................................................................................ 13 
2  Materials and Methods ............................................................................................ 14 
Media and bacterial growth conditions ........................................................... 14 
Ethanol precipitation of uronic acids .............................................................. 17 
Uronic acid quantitation assay ........................................................................ 17 
Acetylation quantitation assay ........................................................................ 18 
Construction and conjugation of algX complementation plasmid .................. 19 
iv 
 
Construction and conjugation of algX H176A plasmid .................................. 23 
Isolation of ribonucleic acid............................................................................ 26 
Real-time polymerase chain reaction .............................................................. 29 
Construction of reporter fusion plasmids for use in beta-galactoside assays . 30 
Beta-galactosidase assay ................................................................................. 34 
5’ Rapid Amplification of cDNA Ends (5’ RACE) ........................................ 34 
Modification of Strep-II tag® vector pASK-IBA63b for use in Pseudomonas
................................................................................................................... 35 
AlgF-Strep-II tagged protein induction and purification ................................ 39 
SDS-PAGE ..................................................................................................... 40 
Immunoblot analysis ....................................................................................... 41 
2-D Redox SDS-PAGE ................................................................................... 42 
Protein identification by mass spectrometry analysis ..................................... 42 
Construction of algF C194S plasmid ............................................................. 43 
3  Acetylation of Uronic Acids Produced by Alginate Biosynthesis Mutants ............ 48 
Evaluation of uronic acid recovery techniques ............................................... 48 
Analysis of uronic acid acetylation in mutant strains ..................................... 51 
4  Involvement of the algX Alginate Biosynthesis Gene in Alginate Acetylation ..... 61 
Confirmation of the non-polarity of an algX::Gm mutation ........................... 61 
Effect on acetylation of a mutation of a conserved amino acid in algX ......... 69 
v 
 
Discussion ....................................................................................................... 80 
5  Transcriptional Analysis of the Alginate Biosynthesis Operon .............................. 81 
Effect of culture media on acetylation of alginate produced by FRD1 .......... 81 
Sequence analysis of upstream regions of alginate biosynthesis genes .......... 92 
Demonstration of promoter activity in regions upstream of algG and algI 
alginate biosynthesis genes ..................................................................... 100 
Attempted identification of mRNA start sites in regions upstream of algG and 
algI alginate biosynthesis genes.............................................................. 104 
Evaluation of relative transcript levels of alginate biosynthesis genes from 
FRD1 grown in Luria-Bertani, MacConkey and Modified Alginate 
Promoting media ..................................................................................... 104 
Discussion ..................................................................................................... 112 
6  Involvement of Disulfide Bonding in AlgF Protein Interactions.......................... 121 
Generation of recombinant AlgF protein and detection of interacting proteins
................................................................................................................. 121 
Construction of AlgF site-directed mutant ................................................... 139 
Discussion ..................................................................................................... 140 
7  Conclusions ........................................................................................................... 142 
References ................................................................................................................................... 144 
Vita .............................................................................................................................................. 148 
 
vi 
 
List of Tables 
Table 1.  Description of bacterial strains ...................................................................................... 15 
Table 2.  Description of bacterial plasmids .................................................................................. 16 
Table 3.  Oligonucleotides ............................................................................................................ 22 
Table 4.  Real-time primers .......................................................................................................... 28 
Table 5.  Characteristics of alginate recovery techniques important to downstream applications 50 
Table 6.  Characteristics of select P. aeruginosa alginate biosynthesis mutant strains relating to 
uronic acid production ...................................................................................................... 59 
Table 7.  Beta-galactosidase activity of lacZ fusion contructs containing upstream regions of 
alginate biosynthesis genes in FRD1 .............................................................................. 103 
Table 8.  Fold increase in normalized transcript levels of alginate biosynthesis genes in P. 
aeruginosa strain FRD1 grown in M.A.P. media over those grown in MacConkey media
......................................................................................................................................... 109 
 
  
vii 
 
List of Figures 
Figure 1.  Model for polymerization, transport and acetylation of alginate in P. aeruginosa and 
schematic representation of alginate biosynthesis operon. ................................................. 5 
Figure 2.  Structure of uronic acid components showing acetylated mannuronate. ..................... 11 
Figure 3.  Levels of uronic acid produced by P. aeruginosa strains. ........................................... 53 
Figure 4.  Levels of acetylation of uronic acids produced by P. aeruginosa strains. ................... 56 
Figure 5.  Partial protein sequence alignment of P. aeruginosa AlgJ and AlgX showing the 
conserved motif present in a subset of type II membrane proteins. .................................. 62 
Figure 6.  Levels of uronic acid produced by P. aeruginosa strains FRD1 and algX 
complementation strain JLP121. ....................................................................................... 65 
Figure 7.  Levels of acetylation of uronic acids produced by P. aeruginosa strain FRD1 and algX 
complementation strain JLP121. ....................................................................................... 67 
Figure 8.  Schematic representation of alginate biosynthesis algX gene H176A site-directed 
mutation and replicative plasmid pMF54. ........................................................................ 70 
Figure 9.  P. aeruginosa FRD1, JLP4, JLP121, and JLP135 strains after overnight growth on 
Luria-Bertani agar at 37°C. ............................................................................................... 73 
Figure 10.  Levels of uronic acid produced by P. aeruginosa strains JLP121 and algX H176A 
mutation strain JLP135. .................................................................................................... 76 
Figure 11.  Levels of acetylation of uronic acids produced by P. aeruginosa strain JLP121 and 
algX H176A mutation strain JLP135. ............................................................................... 78 
Figure 12.  Levels of uronic acids produced by P. aeruginosa strain FRD1 when grown in un-
supplemented Luria-Bertani culture media and in Luria-Bertani media  supplemented 
with 13.6 mM 3-(N-morpholino)-propane-sulfonic acid (MOPS). .................................. 83 
viii 
 
Figure 13.  Levels of acetylation of uronic acids produced by P. aeruginosa strain FRD1 when 
grown in un-supplemented Luria-Bertani culture media and in Luria-Bertani media  
supplemented with 13.6 mM 3-(N-morpholino)-propane-sulfonic acid (MOPS). ........... 85 
Figure 14.  Levels of uronic acids produced by P. aeruginosa strain FRD1 when grown in 
MacConkey and Modified Alginate Producing (M.A.P.) culture media. ......................... 88 
Figure 15.  Levels of acetylation of uronic acids produced by P. aeruginosa strain FRD1 when 
grown in MacConkey and Modified Alginate Promoting (M.A.P.) culture media. ......... 90 
Figure 16.   Upstream region (100 nt) of P. aeruginosa alginate biosynthesis gene algX with 
potential -12 and -24 consensus regions highlighted in gray. ........................................... 93 
Figure 17.  Sequence alignment of the upstream regions of the alginate biosynthesis gene algG 
from P. aeruginosa and A. vinelandii. .............................................................................. 96 
Figure 18.  Upstream region (240 nt) of P. aeruginosa alginate biosynthesis gene algI with 
potential -10 and -35 consensus regions highlighted in gray. ........................................... 98 
Figure 19.  Schematic representation of alginate biosynthesis gene upstream regions and lacZ 
reporter plasmid pSS269 listing the strain generated by each fusion. ............................ 101 
Figure 20.  Normalized transcript levels of alginate biosynthesis genes in P. aeruginosa strain 
FRD1 grown in Luria-Bertani media. ............................................................................. 106 
Figure 21.  Normalized transcript levels of alginate biosynthesis genes in P. aeruginosa strain 
FRD1 grown in MacConkey media and Modified Alginate Promoting (M.A.P.) media.
......................................................................................................................................... 110 
Figure 22.  Upstream region (130 nt) of P. aeruginosa alginate biosynthesis transcriptional 
regulator gene algR with key areas indicated. ................................................................ 114 
ix 
 
Figure 23.  Model of P. aeruginosa alginate biosynthesis operon showing the PalgG and PalgI 
promoter sites. ................................................................................................................. 116 
Figure 24.  Schematic representation of commercial C-terminal Strep-II tag® vector pASK-
IBA63b altered for use in P. aeruginosa. ....................................................................... 122 
Figure 25.  Growth curves of P. aeruginosa strains FRD1 (CF isolate), FRD1175 (FRD1ΔalgF), 
and JLP113 (FRD1175 with AlgF-Strep-II tag). ............................................................ 124 
Figure 26.  Immunoblot showing AlgF expression in FRD1, FRD1175, and JLP113 across a time 
course. ............................................................................................................................. 126 
Figure 27.  Levels of uronic acid produced by P. aeruginosa strains FRD1, FRD1175, and 
JLP113. ........................................................................................................................... 129 
Figure 28.  Levels of acetylation of uronic acids produced by P. aeruginosa strains FRD1, 
FRD1175, and JLP113. ................................................................................................... 131 
Figure 29 A and B.  Immunoblot of affinity purified AlgF subjected to SDS-PAGE under 
reducing and non-reducing conditions. ........................................................................... 134 
Figure 30.  Affinity purified AlgF subjected to 2-D Redox SDS-PAGE. .................................. 137 
 
 
x 
 
Abstract 
EXPLORING THE MECHANISM OF ALGINATE ACETYLATION IN PSEUDOMONAS 
AERUGINOSA 
Janice Lynne Paletta 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2010 
 
Major Director:  Dennis E. Ohman, Ph.D. 
Chairman, Department of Microbiology and Immunology 
 
 
 
 The opportunistic pathogen P. aeruginosa is the leading cause of morbidity and mortality 
in cystic fibrosis patients.  During chronic infection of the cystic fibrosis lung, P. aeruginosa 
undergoes conversion to a mucoid phenotype, constitutively producing the exopolysaccharide 
alginate, composed of the uronic acids -D-mannuronate and -L-guluronate.   This alginate 
production contributes significantly to virulence in the cystic fibrosis lung.  Evidence suggests 
that the acetylation state of the mannuronate component of the alginate influences the ability of 
components of the immune system to phagocytose the organism.  To garner new and relevant 
information regarding the mechanism of alginate acetylation in Pseudomonas aeruginosa, a 
variety of approaches were undertaken.  Analysis of the alginate produced by algX, algG, and 
algK alginate biosynthesis mutants revealed that the small oligouronides they produced were 
unacetylated.  This strongly supports the hypothesis that the mannuronates are acetylated in 
periplasm, and that a polymer of at least some specific size is required. 
xi 
 
 While three alginate biosynthesis gene products (AlgI, AlgJ, and AlgF) have been shown 
to be involved in alginate acetylation, another gene in the cluster, algX, shares 30% identity with 
one of them and thus generates speculation as to its potential involvement in the process.  To test 
this possibility, an algX mutant was complemented with a plasmid carrying a mutation at a 
conserved residue shown to be required for alginate acetylation in the homologous protein.  
Analysis of alginate from this construct suggested that AlgX is not involved in alginate 
acetylation. 
 To determine if changes in levels of alginate acetylation are accomplished at the 
transcriptional level, transcript levels of several alginate biosynthesis genes in different media 
were determined by real-time PCR.  As qRT-PCR had not been previously performed on any of 
the alginate biosynthesis genes, this yielded important information about the transcription of the 
operon.  In addition, beta-galactosidase assays on upstream regions of several biosynthesis genes 
identified two previously unrecognized promoters, one upstream of algG and one upstream of 
algI. 
 The remaining approach was to examine protein interactions of AlgF, the protein product 
of one of the three acetylation genes.  2-D redox SDS-PAGE gels indicated that disulfide 
bonding may be important for interactions with this protein.  While mass spectrometry was 
unable to identify the binding partners of AlgF, efforts are ongoing to create a mutation in the P. 
aeruginosa genome that changes the cysteine residue in AlgF to a serine residue.  This would be 
a definitive method for determining the importance of disulfide bonding in AlgF. 
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Introduction 
 
The genus Pseudomonas 
 The genus Pseudomonas includes a diverse array of species covering a very broad host 
range.  In addition to many innocuous soil and water species, members of the genus 
Pseudomonas include agricultural pathogens such as P. syringae, which causes bacterial speck in 
tomatoes, and P. tolaasii, the causative agent of brown blotch disease in mushrooms, as well as 
the opportunistic human pathogen, P. aeruginosa.  This gram-negative bacterium is able to cause 
a myriad of infections in a human host, including folliculitus, corneal ulcers, endocarditis and 
bacteremia [1].  One of the most devastating infections, caused by P. aeruginosa strains 
constitutively producing the mucoid exopolysaccharide alginate, occurs in the lungs of 
immunocompromised patients or those individuals suffering from the genetic disease cystic 
fibrosis.  Members of this genus are capable of surviving in very diverse environments, from oil 
spills to the human lung, in part because of their ability to metabolize a wide variety of 
substances to fulfill their nutritional requirements.  Some species of Pseudomonas carrying 
degradative plasmids are capable of metabolizing hydrocarbons and other toxic organic 
compounds for survival and are often targeted by industry for commercial usage [2].  Another 
key factor that contributes to the ability of members of this genus to survive is their natural 
resistance to antibiotics.  P. aeruginosa strains possess multiple means of resistance such as 
plasmid-encoded -lactamases, enzymes that modify  aminoglycosides by acetylation or 
adenylation, multidrug efflux pumps and regulation of outer membrane porins [3] [1].  This 
natural antibiotic resistance works in concert with other virulence factors, such as proteases, 
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hemolysins, alginate, pili, and toxins to make P. aeruginosa an important human pathogen and 
an organism of great clinical and research significance. 
 
P. aeruginosa and the cystic fibrosis lung 
  As mentioned previously, one of the most devastating infections caused by P. 
aeruginosa is the chronic lung infection of cystic fibrosis patients with a mucoid strain of the 
bacterium.  Cystic fibrosis is a genetic disease that results from mutations in the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene, the gene product of which is a chloride 
channel present in epithelial cells found in the tissues of the intestine, pancreas, sweat ducts, and 
lungs [4].  A consequence of the malfunctioning chloride channel is the production of 
abnormally thick mucous secretions that can block organ passages and cause nutritional 
deficiencies, breathing complications and lung damage.  The uncleared mucus in the lungs 
contributes to an environment that is conducive to the growth of various bacterial species.  
Haemophilus influenzae, Staphylococcus aureus, and P. aeruginosa can all thrive in this 
environment and typically colonize patients with cystic fibrosis [4].  Non-mucoid strains of P. 
aeruginosa will colonize the lung early in the lives of cystic fibrosis patients; however, the 
conversion to a mucoid strain often signals the rapid and severe deterioration of pulmonary 
function. Mucoid conversion of P. aeruginosa is often due to mutations in the mucA gene, 
encoding an anti-sigma factor, that cause the constitutive transcription of the alginate 
biosynthesis operon [5].  This conversion results in the excretion of alginate and is accompanied 
by the coordinate regulation of other genes such as the down regulation of flagellar genes and the 
loss of the LPS O-side chain aiding in the bacteria’s survival within the lung environment [6] [7]. 
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Alginate biosynthesis operon 
 The production of alginate in P. aeruginosa is due to the expression of the algD operon 
and the algC gene, located outside of the algD operon and dually involved in lipopolysaccharide 
biosynthesis [8].  The algD operon consists of 12 genes encoding proteins with putative 
structural and enzymatic functions responsible for the generation of acetylated alginate polymer 
(Figure 1 A. and B.).  Current evidence supports the following proposed roles for the alginate 
biosynthesis proteins:  AlgD -  GDP-mannose dehydrogenase [9], Alg8 – glycosyltransferase 
[10], Alg44 – polymerization [11], AlgK – scaffold [12], AlgE – outer membrane porin [13], 
AlgG – epimerase [14], AlgX – scaffold [15], AlgL – alginate lyase [16],  AlgI – acetylation 
[17], AlgJ – acetylation [17], AlgF – acetylation [18], and AlgA – phosphomannose isomerase 
and GDP-mannose pyrophosphorylase [19, 20].  The algC gene encodes a phosphomannomutase 
[8].   
 Many genetic studies have provided valuable information regarding how the alginate 
polymer is synthesized and exported, however, there are still aspects of the process for which the 
mechanism is unclear.  Genetic and metabolic studies have shown that the algD, algC, and algA 
gene products are all required to ultimately form GDP-mannuronate, the uronic acid precursor 
needed for the formation of the alginate polymer [8] [20] [21].  Mutation of the alg8 gene, an in 
vitro assay, and structural similarities all indicate that alg8 encodes a glycosyltransferase and is 
responsible for polymerization [22-24].  Insertional mutation of alg44 has shown that the alg44 
gene product is also required for alginate polymerization and likely functions along with Alg8 in 
polymerization and transport of the sugar across the inner membrane [25].  Deletion of the algI, 
algJ, or algF gene results in the production of a non-acetylated alginate polymer indicating that 
all of these genes are required for the acetylation of alginate [17, 18].  It is unclear, however, 
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how the exact mechanism of acetylation occurs.  Both genetic and enzymatic studies have shown 
that the algG gene product is a C5-mannuronan epimerase [26], and demonstrated lyase activity 
from expression of the P. aeruginosa algL gene product in E. coli supports the role of AlgL as an 
alginate lyase [16].  Both of these genes are believed to function in dual roles as the deletion of 
the algG, algL, algX, or algK gene results in the secretion of small uronic acid fragments, 
demonstrated to be products of AlgL degradation [15, 27].  This suggests that a periplasmic 
scaffold complex composed of AlgG, AlgL, AlgX and AlgK may be required for successful 
polymerization and secretion of alginate and that in the absence of any of these scaffold proteins 
the alginate polymer can be accessed and degraded by the alginate lyase [27].   Finally, genetic 
and immunologic studies have demonstrated that algE encodes an outer membrane porin through 
which the alginate polymer is secreted [13, 28]. 
 Alginate biosynthesis gene expression is regulated by AlgT, AlgR, AlgB and AmrZ.  
Environmental signals such as high osmolarity, starvation and oxygen availability have been 
shown to influence alginate production, however, the exact manner by which each of these 
signals leads to an increase in alginate production still requires investigation [29].   
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Figure 1.  Model for polymerization, transport and acetylation of alginate in P. aeruginosa 
and schematic representation of alginate biosynthesis operon.  A.  Alg8 and Alg44 form a 
polymerase complex while AlgG, AlgX, AlgL, and AlgK form a hypothetical scaffold complex 
for the transport of alginate through the periplasm to AlgE, an outer membrane secretin.  AlgI, 
AlgJ and AlgF are responsible for acetylation of the alginate polymer.  Black circles represent 
acetyl groups; grey hexagons represent mannuronates and guluronates.  B.  Schematic 
representation of twelve gene operon responsible for alginate production showing gene order, 
intergenic spaces, and the PalgD promoter.   
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Regulation of alginate biosynthesis in Pseudomonas aeruginosa 
 Regulation of alginate production in P. aeruginosa is a multi-layered process, some 
aspects of which are not yet fully understood.   The promoter for the alginate biosynthesis 
operon, PalgD, consists of an approximately one kilobase region upstream of the algD coding 
region, and is regulated by a sigma 22 factor, AlgT [30].  This sigma factor is also referred to as 
AlgU, sigma 22, and RpoE [31].  In non-mucoid strains of P. aeruginosa, AlgT is sequestered in 
the cytoplasm by the anti-sigma factor MucA, preventing activation of PalgD and subsequent 
transcription of alginate biosynthesis genes [30].  Mutations in mucA can impair the ability of 
MucA to bind AlgT and results in unregulated production of alginate.  One study determined that 
84% of mucoid P. aeruginosa isolates from cystic fibrosis patients had a mutation in the mucA 
gene [32].  Unregulated alginate production can also result from a mutation in mucB, causing 
constitutive activation of the operon [33].  The MucB protein is believed to be localized to the 
periplasm and may be part of a signal transduction complex which acts through MucA to control 
activity of AlgT [34].  
 In addition to AlgT, transcription from PalgD requires two response regulators, AlgR and 
AlgB, and an activator, AmrZ [35] [36] [32].  It has been demonstrated that transcription of algR, 
algB and amrZ are all dependent upon AlgT [37, 38].  The alginate biosynthesis gene algC, 
while expressed independently of the other biosynthesis genes, is also subject to regulation by 
AlgR [39]. 
 It is possible that under certain conditions a sigma factor besides AlgT may be involved 
in alginate regulation.  A potential sigma 54 (RpoN) binding site was identified in the upstream 
regions of algD and algR and fusions of those promoter regions to a reporter showed a decrease 
in transcription in a sigma 54 mutant strain compared to wild type [40].  Additionally, sigma 54 
9 
 
was shown to be necessary for alginate production in a mucoid strain with mutations in unknown 
genes, designated muc23 [41].  This same work highlights the possibility that there may be some 
level of competition between AlgT and sigma 54 due to the overlap of promoter consensus 
sequences.  
 
Regulation of alginate biosynthesis in Azotobacter vinelandii 
 Regulation of alginate biosynthesis in A. vinelandii is somewhat different than in P. 
aeruginosa.  Unlike the alginate biosynthesis operon in Pseudomonas that appears to be 
organized into just one transcriptional unit driven by PalgD, the alginate biosynthesis operon of A. 
vinelandii is organized into four transcriptional units.  One includes algD with transcription 
being driven from two promoters.  Promoter P1 is a sigma D type promoter, while P2 is a sigma E 
type promoter similar to AlgT [42].  A sigma S type promoter (involved in the general stress 
response) has been shown to drive transcription of alg8, alg44, algK and algE as a second 
transcriptional unit [43].  The third operon within the biosynthetic gene cluster includes genes 
algG through algF and sequence at the -10 and -35 regions upstream of the mRNA start site do 
not correspond to any known promoter consensus sequences.  They do, however, share similarity 
to the -10 and -35 regions of the algR promoter region [44].  The final transcriptional unit is 
composed only of algA, but the promoter has not been characterized.  It was demonstrated that 
transcription from this promoter alone was insufficient to generate a mucoid phenotype  [44]. 
 The differences in alginate regulation between A. vinelandii and P. aeruginosa may be 
due in part to the ability of A. vinelandii to form metabolically dormant cysts during its lifecycle, 
of which alginate is a major component [45]. 
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Alginate acetylation and opsonization 
 The alginate produced by mucoid strains of P. aeruginosa is a linear copolymer 
composed of the uronic acids -D-mannuronate and its C-5 epimer -L-guluronate [46].  Uronic 
acids differ from their parent sugars by the oxidation of the alcohol group (CH2OH) to a carboxyl 
group (COOH).  The alginate produced by P. aeruginosa contains repeating units of 
mannuronate interspersed with guluronate, but does not contain repeating blocks of guluronate.  
Since the guluronic acid readily binds Ca
2+
, which stabilizes the structure, the amount of 
guluronate in the polymer affects physical properties such as viscosity [10].  Another factor that 
can affect the properties of the alginate is the acetylation of the oxygen at the C-2 and C-3 
positions of the mannuronate (Figure 2).  Acetylation increases the hydration of the polymer and 
has been shown to affect the sequence of guluronate and mannuronate units [46].  In a biological 
system, the alginate secreted by P. aeruginosa is a potent virulence factor that has been shown to 
block immunologic epitopes to inhibit antibody binding [47], inhibit the chemotaxis of 
neutrophils [48], prevent the diffusion of some antibiotics [49], and scavenge free radicals [50]. 
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Figure 2.  Structure of uronic acid components showing acetylated mannuronate. 
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Research Objectives 
 While the importance of the role played by alginate acetylation in virulence is clear, the 
exact mechanism of how the polymer is acetylated is still undetermined.  It is not known if all of 
the proteins important in alginate acetylation have been identified, as it is likely that there may 
be interacting proteins that originate outside of the alginate biosynthesis operon (as in AlgC).  In 
spite of the large volume of data available on regulation in P. aeruginosa from the algD 
promoter, there has been little work done regarding transcription or regulation within the gene 
cluster [13, 51].  In an attempt to broaden the current knowledge in these areas, this work focuses 
on the following three objectives: 
1)  Characterize the alginate acetylation of available alginate biosynthesis mutants.  
While in most cases alginate production by mutant strains has been characterized, 
acetylation has not been studied to the same extent.  Additional information may be 
obtained by studying acetylation in conjunction with uronic acid production. 
2) Identify other proteins involved in acetylation.  This includes examining a possible 
role for algX, as well as isolating any proteins that may interact with AlgF.  
3) Perform transcriptional analysis on genes within the alginate biosynthesis operon, 
especially those that may affect acetylation.  Quantitative real-time PCR has not been 
performed on genes within the operon and any information gathered would be 
beneficial.  Results of the qRT-PCR can provide direction for additional 
transcriptional or translational studies. 
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Materials and Methods 
 
Media and bacterial growth conditions 
 Pseudomonas was typically cultured in Luria-Bertani liquid media at 37°C with shaking.  
For maintenance of ampicillin-resistance plasmids in P. aeruginosa, carbenicillin at 150 µg/ml 
was added to the media.  In some cases, a Modified Alginate Promoting media consisting of 
0.017 M K2HPO4, 7.5 mM NaH2PO4, 0.02 M MgSO4, 0.12 M L-glutamate, and 0.1 M D-
gluconate was used for P. aeruginosa culture.  MacConkey media (Difco™) and Pseudomonas 
Isolation Agar (Difco™) were reconstituted with water per the manufacturer’s instructions. 
 E. coli was also typically cultured in Luria Bertani liquid media at 37°C with shaking.  
Where necessary, antibiotics were added at the following concentrations:  ampicillin – 100 
µg/ml, kanamycin – 30 µg/ml, and gentamycin – 15 µg/ml. 
 Growth on solid media for both bacteria was typically carried out on Luria-Bertani agar 
plates with addition of antibiotics at the concentrations stated above where required. 
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Table 1.  Description of bacterial strains 
Strains Genotype and/or Phenotype* Source 
     
P. aeruginosa     
 FRD1 Prototrophic, mucA22, mucoid Ohman lab strain 
 FRD1100 FRD1algK::Gm
r
 Ohman lab strain 
 FRD1108 FRD1alg8::Gm
r
 Ohman lab strain 
 FRD1144 FRD1alg44::Gm
r
 Ohman lab strain 
 FRD1175 FRD1ΔalgF, mucoid Ohman lab strain 
 FRD1200 FRD1algG::Gm
r
, non-mucoid Ohman lab strain 
 FRD2 FRD1 revertant, non-mucoid Ohman lab strain 
 FRD462 FRD1algG4, mucoid Ohman lab strain 
 JLP4 FRD1algX::Gm
r
, non-mucoid Ohman lab strain 
 JLP98 FRD1 with pJP11, mucoid This study 
 JLP113 FRD1175 with pJP11, mucoid This study 
 JLP121 FRD1algX::Gm
r
, pJP12, mucoid This study 
 JLP135 FRD1algX::Gm
r
, pJP14, Cb
r
, mucoid This study 
 JLP162 pJP20, Cb
r
 This study 
 JLP173 pJP16, Cb
r
 This study 
 JLP179 pJP18, Cb
r
 This study 
 JLP182 pJP19, Cb
r
 This study 
 JLP184 pJP17, Cb
r
 This study 
 JLP196 pLW149a This study 
     
E. coli     
 JLP102 pJP12  This study 
 JLP3 Kan
r
, pRK2013  Ohman lab strain 
 JLP54 pUC19, Ap
r
  Ohman lab strain 
 JLP106 pJP13, Ap
r
  This study 
 JLP131 pJP14, Ap
r
  This study 
 JLP149 pSS269, Ap
r
  Ohman lab strain 
 JLP159 pSS269, pJP16  This study 
 JLP170 pSS269, pJP17  This study 
 JLP167 pSS269, pJP18  This study 
 JLP165 pSS269, pJP19  This study 
 JLP162 pSS269, pJP20  This study 
 LW1569 pSS269, pLW149a  Ohman lab strain 
 JLP30 pASK-IBA63b-plus  IBA GmbH 
 JLP33 pSS125  Ohman lab strain 
 JLP32 pSS124  Ohman lab strain 
 JLP35 pJP2  This study 
 JLP43 pJP5  This study 
 JLP65 pJP11  This study 
 JLP150 pJP21  This study 
 JLP148 pEX18Ap  Ohman lab strain 
 JLP153 pJP22  This study 
     
*Abbreviations:  Ap
r
, ampicillin resistance; Cb
r
, carbenicllin resistance; Gm
r
, gentamicin resistance; Kan
r
, kanamicin 
resistance 
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Table 2.  Description of bacterial plasmids 
Plasmids Genotype* Source 
    
pASK-IBA63b Ptet >Strep-II tag,  Ap
r
, Tet-repressor  IBA GmbH 
pEX18Ap lacZα, oriT, Ap
r
, Suc
s
  [52] 
pJP2 pASK-IBA63b-plus with oriT  This study 
pJP5 pJP2 with mSF  This study 
pJP11 pJP5 with algF  This study 
pJP12 pMF54 with algX  This study 
pJP13 pUC19 with algX H176A  This study 
pJP14 pMF54 with algX H176A  This study 
pJP16 pSS269 with algG upstream  This study 
pJP17 pSS269 with algX upstream  This study 
pJP18 pSS269 with algJ upstream  This study 
pJP19 pSS269 with algF upstream  This study 
pJP20 pSS269 with algI upstream  This study 
pJP21 pUC19 with algF C194S  This study 
pJP22 pEX18Ap with algF C194S  This study 
pLW149a pSS269 with algD upstream  Ohman lab construct 
pMF54 Ptrc, Ap
r
, oriT, SF, lacI
q
  Ohman lab construct 
pRK2013 ColE1-Tra(RK2)
+
, Kan
r
  [53] 
pSS124 pUC1819 with mSF  [54] 
pSS125 pUC1819 with oriT  [54] 
pSS269 trp-lacZ1, mSF, oriT, Ap
r
  Ohman lab contruct 
pUC19 Ap
r
  Ohman lab 
    
*Abbreviations:  Ap
r
, ampicillin resistance; Kan
r
, kanamicin resistance; mSF, mini stabilizing fragment for replication in 
P. aeruginosa; Suc
s
, sucrose sensitive 
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Ethanol precipitation of uronic acids 
 For recovery of uronic acids from P. aeruginosa strains, bacteria was cultured overnight 
in liquid media (approximately 16 hours) at 37°C with shaking, then centrifuged at 10,000 x g 
for one hour at 4°C to pellet bacterial cells.  Supernatants were transferred to fresh centrifuge 
tubes, 2.5 volumes of 95% ice cold ethanol were added, and then supernatants with ethanol were 
centrifuged for 20 minutes at 4°C at 10,000 x g.  Supernatants were decanted and uronic acid 
pellets were re-suspended in 2-5 ml Milli-Q water by shaking at 30-37°C. 
 
Uronic acid quantitation assay 
 The method used for uronic acid quantitation is based on that of Dische [55].  Required 
reagents were prepared in advance where possible or on the day of use where required.  A stock 
borate reagent was prepared by dissolving 24.74 g of H3BO3 in 45 ml of 4 M KOH, brought to 
100 ml by the addition of de-ionized water.  A 0.1% carbazole solution was prepared by 
dissolving 0.1 g of carbazole in 100 ml of ethanol.  Both of these reagents were stored at room 
temperature until use.  On the day of use, a sulphuric acid-borate reagent (0.1 M H3BO3) was 
made by combining 0.750 ml of stock borate solution with 30 ml of ACS analytical grade 
H2SO4. 
 Triplicate samples were assayed for uronic acid content by cooling one ml of sulphuric 
acid-borate reagent in glass tubes on ice for 2 minutes before adding 100 µl of alginate solution.  
The solution was allowed to cool 2 minutes then vortexed and returned to ice for another 2 
minutes.  Thirty-three microliters of 0.1% carbazole solution was added, the samples vortexed, 
and then returned to ice for 2 minutes.  Sample tubes were then placed in a heat block and 
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incubated at 55°C for 30 minutes before returning to ice.  Absorbance was immediately read at 
530 nm and the values recorded. 
 In order to equate observed spectrophotometric values with uronic acid amounts, a 
standard curve was prepared by assaying concentrations of sodium alginate isolated from 
Macrocystis pyrifera (Sigma) ranging from 10 µg/ml to 100 µg/ml.  A 2 mg/ml stock solution of 
sodium alginate was prepared by dissolving 0.040 g of sodium alginate in 20 ml of saline by 
shaking at 37°C for one hour.  A 100 µg/ml dilution of the sodium alginate stock solution was 
made and then further diluted with saline to concentrations of 80, 60, 50, 40, 30, 20, and 10 
µg/ml.  One hundred microliters of each solution were assayed as outlined above and the 
resulting absorbance readings were used to generate a standard curve.  
 
Acetylation quantitation assay 
 The method used for quantitation of acetyl groups present in alginate solutions is based 
on that described by Hestrin [56].  Required reagents were prepared within three hours of use.  A 
70 mM ferric perchlorate solution was prepared by dissolving 0.248 g of iron perchlorate in 5 ml 
of 1 M perchloric acid and 5 ml of Milli-Q water.  Alkaline hydroxylamine (0.35M 
hydroxylamine, 0.75 M NaOH) was prepared by combining 0.243 g hydroxylamine, 0.750 ml 10 
M NaOH, and 9.25 ml Milli-Q water. 
 Triplicate samples were assayed for acetyl group content by adding 500 µl of alkaline 
hydroxylamine to 500 µl of alginate solution in a glass tube.  The solution was mixed by 
pipetting or vortexing and then incubated 10 minutes at 25°C.  After incubation, 500 µl of 1 M 
perchloric acid was added and the solution was mixed by pipetting or vortexing.  Five hundred 
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microliters of 70 mM ferric perchlorate was added to the solution and mixed by pipetting before 
reading the absorbance of the solution at 500 nm. 
 In order to equate observed spectrophotometric values with amounts of acetyl group, a 
standard curve was prepared by assaying ethyl acetate containing amounts of acetyl group 
ranging from 0.0043 µg to 0.2150 µg.  A 1:1000 dilution of 99.9% pure ethyl acetate (F.W. 
88.11) was prepared containing 0.2150 µg of acetyl group (F.W. 43.04) per 500 µl, and then 
further diluted to amounts of 0.1720, 0.1290, 0.0860, 0.0645, 0.0516, 0.0387, 0.0258, 0.0129, 
and 0.0043 µg of acetyl group.  Five hundred microliters of each solution were assayed as 
outlined above and the resulting absorbance readings were used to generate a standard curve.  
 
Construction and conjugation of algX complementation plasmid 
The algX coding sequence was amplified by polymerase chain reaction from P. 
aeruginosa FRD1 strain using primers 1 and 2 containing BspHI and HindIII restriction sites.  
The reaction was fractionated on a 1% agarose gel, excised, and purified using the QIAquick Gel 
Extraction Kit by Qiagen.  The manufacturer’s protocol for gel purification using a 
microcentrifuge was followed.  Once purified, the product was digested using BspHI and HindIII 
restriction enzymes from New England Biolabs.  In brief, 5 µl NEB Buffer #2, 20 µl purified 
algX PCR product, 1.5 µl BspHI, 1.5 µl HindIII, and 22 µl Milli-Q were incubated for three 
hours at 37°C.  The digestion reaction was heat inactivated by incubation at 65°C for 20 minutes, 
fractionated on an agarose gel, and then excised and purified.  Plasmid pMF54 was purified from 
an overnight culture of JLP15 using the QIAprep® Miniprep Kit by Qiagen following the 
manufacturer’s protocol for plasmid DNA purification using a microcentrifuge.  After isolation, 
the purified plasmid was digested using NcoI (generates 5’ overhang identical to that created by 
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digestion with BspHI) and HindIII restriction enzymes from New England Biolabs.  The 
digestion reaction included 3 µl NEB Buffer #2, 20 µl purified pMF54, 1.5 µl NcoI, 1.5 µl 
HindIII, and 4 µl Milli-Q and was incubated for two hours at 37°C.  The digestion reaction was 
then fractionated on an agarose gel, verified for digestion by comparison against uncut plasmid, 
and excised and purified.  Purified and digested algX was ligated into the pMF54 plasmid in a 20 
µl overnight reaction at 16°C as follows: 4 µl purified algX, 2 µl pMF54, 1 µl T4 DNA Ligase 
(New England Biolabs); 2 µl 10X T4 DNA Ligase Reaction Buffer; and 11 µl Milli-Q water.  
Ligation reactions were transformed into chemically competent DH5α cells as follows:  8 µl of 
ligation reaction was gently mixed into 100 µl of DH5α cells that had been thawed on ice.  
Reaction was incubated on ice for 45 minutes and then cells were heat shocked for 40 seconds in 
a 42°C water bath.  Cells were returned to ice for one minute, 600 µl of Luria-Bertani media was 
added, and cells were allowed to recover for one hour at 37°C with shaking.  Cells were then 
plated on Luria-Bertani plates with ampicillin (100 µg/ml) and incubated overnight at 37°C.  
Resulting colonies were screened by PCR to confirm the presence of the algX insert.  Successful 
ligation and transformation for algX in pMF54 resulted in plasmid pJP12 and E. coli strain 
JLP102. 
Transfer of the pMF54 plasmid construct into the P. aeruginosa algX::Gm strain JLP4 
was accomplished by conjugation.  E. coli strain JLP3 containing the helper plasmid pRK2013 
was used to facilitate the conjugation.  Cultures of JLP4, JLP3, and JLP102 were started from 
individual colonies and incubated in Luria-Bertani (LB) media, with antibiotics where 
appropriate, at 37°C with shaking.  After overnight incubation, 60 µl of the E. coli donor culture 
(JLP102) was sub-cultured into 3 ml of fresh LB media with 100 ug/ml ampicillin, and 60 µl of 
JLP3 (helper culture) was sub-cultured into 3 ml of fresh LB media supplemented with 30 µg/ml 
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kanamycin.  Both the donor and the helper sub-cultures were incubated at 37°C with shaking for 
approximately five hours.  For the recipient FRD1algX::Gm strain JLP4, one milliliter of 
overnight culture was combined with one milliliter of fresh LB media and 40 µl of 1M NaNO3 
and incubated without aeration for approximately 5 hours at 37°C.  After incubation, 500 µl 
FRD1algX::Gm recipient strain JLP4 was combined with 600 µl JLP3 helper strain and 600 µl of 
the donor strain (JLP102) and cells were pelleted by centrifugation in a microcentrifuge at 
>13,000 rpm for three minutes.  Supernatant was removed, cells were washed with 500 µl of 
saline, and centrifuged again at >13,000 rpm for three minutes.  Cells were then resuspended in 
30 µl of saline, spotted on a Luria agar plate, and incubated at 30°C.  After overnight incubation, 
the cells were resuspended in three milliliters of saline and varying dilutions were spread on 
plates of ½ Pseudomonas Isolation Agar (PIA) and Luria agar supplemented with 150 µg/ml of 
carbenicillin.  Plates were incubated overnight at 37°C and any resulting conjugants were re-
streaked on fresh ½ PIA and Luria plates with carbenicillin to confirm uptake of the plasmid.  
Successful conjugation resulted in the P. aeruginosa strain JLP121 (FRD1algX::Gm strain with 
algX expressed in trans on the pMF54 plasmid). 
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Table 3.  Oligonucleotides 
Primer Description Sequence (5’-3’) 
1 AlgX BspHI Forward GCTATCCATCATGAATGAAAACCCGCACTTCCCG 
2 AlgX HindIII Reverse GCCATAAGCTTTTACCTCCCGGCCACCGAC 
16 AlgF BspHI Forward GCTATCCATCATGAACCCGATGACCCGCC 
17 AlgF XhoI Reverse GATAGCCTCGAGGTCCGCCTTCACCGGGCG 
24 AlgX H176A Forward GCGACCACGCCTGGACTC 
25 AlgX H176A Reverse GAGTCCAGGCGTGGTCGC 
50 AlgF Outside Forward GCCCGCCTGTATCCCGAG 
51 AlgF Outside Reverse GGCGTCGTGCTTCTTCAGTTC 
52 AlgF C194S Forward CGAGGTGGTCTCCCTGTACG 
53 AlgF C194S Reverse CGTACAGGGAGACCACCTCG 
82 AlgF Outside Forward - Phos GCCCGCCTGTATCCCGAG 
83 AlgF Outside Reverse- Phos GGCGTCGTGCTTCTTCAGTTC 
88 AlgF Beta Oligo Forward 
AATTAGCGCCTGGCCGCCAGCCGCAACGATTGAACGAACACAGCCAAGGCT
GTTTACCCACGGGGCCGAGCGCCCCGCTGAAGAAGAAGCAACGGAGGAAT
ACCC 
89 AlgF Beta Oligo Reverse 
TCGCGGACCGGCGGTCGGCGTTGCTAACTTGCTTGTGTCGGTTCCGACAAA
TGGGTGCCCCGGCTCGCGGGGCGACTTCTTCTTCGTTGCCTCCTTATGGGC
TAG 
90 AlgG Beta Oligo Forward 
AATTTTCAAGCCGGGCGACGCCTACGGGCCGGGCACCGACTCGACCATGCA
CCGCGCCTTCGTCGACTTCATCTGGCGCTTCTGAGCCCCGCGAGGAAACCG
GAC 
91 AlgG Beta Oligo Reverse 
AAGTTCGGCCCGCTGCGGATGCCCGGCCCGTGGCTGAGCTGGTACGTGGC
GCGGAAGCAGCTGAAGTAGACCGCGAAGACTCGGGGCGCTCCTTTGGCCT
GCTAG 
92 AlgI Beta Forward TGAATCGAATTCGGGCGTGGCGGG 
93 AlgI Beta Reverse ATCGGCGGATCCGCCGTCTCTCTCTCTAGAGC 
94 AlgJ Beta Oligo Forward 
AATTCGCCTGGCGCTGCTCCTGCTGTTCGCCGCCTCGGTGCTGAAGCTCTC
CGCGCAGAGCTACTCGCCATTCCTCTACTTCCAGTTCTGAGCGAGGCCCAC
GCC 
95 AlgJ Beta Oligo Reverse 
GCGGACCGCGACGAGGACGACAAGCGGCGGAGCCACGACTTCGAGAGGC
GCGTCTCGATGAGCGGTAAGGAGATGAAGGTCAAGACTCGCTCCGGGTGCG
GCTAG 
96 AlgX Beta Oligo Forward 
AATTAGCAGGACCAGATCCTCGACCTGCTGGTGCGCCAGGACAAGGCGGTG
CTGATCGACCCCGTGGAAAGCCAGGCCGAACTCCAGGACTGAGGACCCAGA
CGC 
97 AlgX Beta Oligo Reverse 
TCGTCCTGGTCTAGGAGCTGGACGACCACGCGGTCCTGTTCCGCCACGACT
AGCTGGGGCACCTTTCGGTCCGGCTTGAGGTCCTGACTCCTGGGTCTGCGC
TAG 
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Construction and conjugation of algX H176A plasmid 
The algX coding sequence was amplified in two portions by overlap extension 
polymerase chain reaction from the P. aeruginosa FRD1 strain using primers 1 and 25, and 
primers 2 and 24 (Table 3).  Primers 1 and 2 contain BspHI and HindIII restriction sites, 
respectively, and anneal to sequences at the beginning and end of the gene.  Primers 24 and 25 
are overlapping reverse complement primers containing mutations at the sequence encoding 
amino acid 176.  The sequence was engineered to alter two nucleotides in the codon 176 
sequence from CAC to GCC.    After amplification the PCR products were fractionated on a 1% 
agarose gel, excised, and purified using the QIAEX II Gel Extraction Kit by Qiagen according to 
the manufacturer’s protocol.  Another PCR reaction was performed to amplify the entire 
mutanagized algX coding region using a mixture of the purified PCR reactions containing the 
two mutanegized portions of the algX gene as template and primers 1 and 2.  The PCR reaction 
was fractionated on a 1% agarose gel, excised, and purified. 
Purified algX H176A was ligated into pUC19 plasmid previously digested with SmaI 
restriction enzyme (New England Biolabs) in a 20 µl overnight reaction at 16°C as follows: 4 µl 
purified algX H176A, 1 µl pUC19, 1 µl T4 DNA Ligase (New England Biolabs); 2 µl 10X T4 
DNA Ligase Reaction Buffer; and 12 µl Milli-Q water.  Ligation reactions were transformed into 
chemically competent DH5α cells as follows:  8 µl of ligation reaction was gently mixed into 
100 µl of DH5α cells that had been thawed on ice.  Reaction was incubated on ice for 45 minutes 
and then cells were heat shocked for 40 seconds in a 42°C water bath.  Cells were returned to ice 
for one minute, 600 µl of Luria-Bertani media was added, and cells were allowed to recover for 
one hour at 37°C with shaking.  Cells were then plated on Luria-Bertani plates with ampicillin 
(100 µg/ml) and incubated overnight at 37°C.  Resulting colonies were screened by PCR to 
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confirm the presence of the algX H176A insert.  Successful ligation and transformation for algX 
H176A in pUC19 resulted in plasmid pJP13 and E. coli strain JLP106. 
To verify that the sequence encoding amino acid 176 in algX had been mutated from 
CAC to GCC and that there were no other unintentional mutations in the coding sequence, strain 
JLP106 was cultured overnight and plasmid pJP13 was purified for sequencing using the 
QIAprep® Miniprep Kit (Qiagen).  Sequencing was performed by the VCU Nucleic Acids 
Research Facilities DNA Sequencing Core (Richmond, VA) and MWG Biotech (High Point, 
NC) on both algX H176A from strain JLP106 (and two additional clones) and wild-type algX 
isolated from P. aeruginosa strain FRD1 for comparison purposes.  Sequencing confirmed the 
presence of the engineered algX H176A mutation and identified four sequence differences in the 
P. aeruginosa FRD1 algX sequence and the published P. aeruginosa PAO1 sequence.   Three of 
these divergent nucleotides resulted in no change to the FRD1 amino acid sequence compared to 
that of PAO1, while the fourth resulted in an amino acid change between the two strains. 
Following sequence verification, purified pJP13 was digested with BspHI and HindIII 
restriction enzymes (New England Biolabs) in a standard 30 µl reaction using 1.5 µl of each 
enzyme and 20 µl of purified plasmid.  The digestion reaction was fractionated on an agarose 
gel, and the algX H176A fragment was excised and purified.  The purified fragment was ligated 
into plasmid pMF54, previously digested with NcoI (generates 5’ overhang identical to that 
created by digestion with BspHI) and HindIII restriction enzymes (New England Biolabs), in a 
standard 20 µl overnight ligation reaction.  Chemically competent E. coli DH5α cells were 
transformed with the ligation reaction as follows:  8 µl of ligation reaction was gently mixed into 
100 µl of DH5α cells that had been thawed on ice.  Reaction was incubated on ice for 45 minutes 
and then cells were heat shocked for 40 seconds in a 42°C water bath.  Cells were returned to ice 
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for one minute, 600 µl of Luria-Bertani media was added, and cells were allowed to recover for 
one hour at 37°C with shaking.  Cells were then plated on Luria-Bertani plates with ampicillin 
(100 µg/ml) and incubated overnight at 37°C.  Resulting colonies were screened by PCR to 
confirm the presence of the algX H176A insert.  Successful ligation and transformation for algX 
H176A in pMF54 resulted in plasmid pJP14 and E. coli strain JLP131. 
Transfer of the pMF54 plasmid construct into the P. aeruginosa algX::Gm strain JLP4 
was accomplished by conjugation.  E. coli strain JLP3 containing the helper plasmid pRK2013 
was used to facilitate the conjugation.  Cultures of JLP4, JLP3, and JLP131 were started from 
individual colonies and incubated in Luria-Bertani (LB) media, with antibiotics where 
appropriate, at 37°C with shaking.  After overnight incubation, 60 µl of the E. coli donor culture 
(JLP131) was sub-cultured into 3 ml of fresh LB media with 100 µg/ml ampicillin, and 60 µl of 
JLP3 (helper culture) was sub-cultured into 3 ml of fresh LB media supplemented with 30 µg/ml 
kanamycin.  Both the donor and the helper sub-cultures were incubated at 37°C with shaking for 
approximately five hours.  For the recipient FRD1algX::Gm strain JLP4, one milliliter of 
overnight culture was combined with one milliliter of fresh LB media and 40 µl of 1M NaNO3 
and incubated without aeration for approximately 5 hours at 37°C.  After incubation, 500 µl 
FRD1algX::Gm recipient strain JLP4 was combined with 600 µl JLP3 helper strain and 600 µl of 
the donor strain (JLP131) were combined and cells were pelleted by centrifugation in a 
microcentrifuge at >13,000 rpm for three minutes.  Supernatant was removed, cells were washed 
with 500 µl of saline, and centrifuged again at >13,000 rpm for three minutes.  Cells were then 
resuspended in 30 µl of saline, spotted on a Luria agar plate, and incubated at 30°C.  After 
overnight incubation, the cells were resuspended in three milliliters of saline and varying 
dilutions were spread on plates of ½ Pseudomonas Isolation Agar (PIA) and Luria agar 
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supplemented with 150 µg/ml of carbenicillin.  Plates were incubated overnight at 37°C and any 
resulting conjugants were re-streaked on fresh ½ PIA and Luria plates with carbenicillin to 
confirm uptake of the plasmid.  Successful conjugation resulted in the P. aeruginosa strain 
JLP135 (FRD1algX::Gm strain with algX H176A expressed in trans on the pMF54 plasmid). 
 
Isolation of ribonucleic acid 
Overnight bacterial cultures were sub-cultured at a dilution of 1:100 into 20 ml of fresh 
media and grown to an OD600 of approximately 0.8.  Cells were harvested from 10 ml of culture 
by centrifugation at 10,000 x g for 15 minutes at 4°C.  RNA was isolated from bacterial cells 
using TRIzol
® 
reagent by Invitrogen and following the manufacturer’s protocol.  In brief, cells 
were lysed in 1 ml of TRIzol
® 
reagent by repetitive pipetting and then incubated five minutes at 
room temperature (~25°C).  Two hundred µl of chloroform was added, samples were shaken by 
hand for 15 seconds, and then incubated at room temperature for 2 minutes.  Samples were 
centrifuged at 12,000 x g for 15 minutes at 4°C to separate the mixture into a phenol-chloroform 
phase, an interphase, and an aqueous phase.  The aqueous phase was removed and RNA was 
precipitated from it using 0.5 ml of isopropyl alcohol.  Samples were incubated at room 
temperature for 10 minutes and then centrifuged at 12,000 x g for 15 minutes at 4°C.  The 
supernatant was removed from the samples and the RNA pellet was washed with 1 ml of 75% 
ethanol.  RNA was re-suspended by vortexing and the samples were centrifuged at 7,500 x g for 
5 minutes at 4°C.  The RNA pellet was air-dried for 6 minutes and redissolved in 30 µl RNase-
free water by pipetting followed by incubation at 55°C for 10 minutes. 
To facilitate efficient removal of any contaminating DNA, nucleic acid quantitation was 
performed on RNA samples by measuring absorbance at 260/280 nm, and, where necessary, 
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samples were diluted to a concentration of approximately 500 µg/ml.  RNA was then treated 
twice using the Ambion
®
 DNA-free™ Kit (Applied Biosystems) and the manufacturer’s 
rigorous DNase treatment protocol as follows.  Three microliters of 10X DNase I Buffer and 1.5 
µl of rDNase I were added to 30 µl RNA samples, mixed, and incubated at 37°C.  After 30 
minutes, an additional 1.5 µl of rDNase I was added and the samples were returned to 37°C for 
another 30 minutes.  Upon completion of the 37°C incubation, 6 µl of DNase Inactivation 
Reagent was added and the samples were incubated at room temperature for two minutes with 
occasional mixing.  Samples were centrifuged in a standard tabletop centrifuge for 1.5 minutes at 
13,000 rpm to pellet DNase Inactivation Reagent and supernatants containing treated RNA were 
transferred to fresh tubes.  Samples were re-quantitated after two treatments to ensure adequate 
260/280 ratios and for use in downstream applications. 
 RNA was stored at -80°C until use. 
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Table 4. Real-time primers 
Primer Description Sequence (5’-3’) 
62 algD RT Forward ACGCGGTCATGAAGTCATTGGT 
63 algD RT Reverse ACGATACGTCGGAGTCCAGCAC 
70 oprF RT Forward CAGCTGGACGTGAAGTTCGA 
71 oprF RT Reverse GAAGTCAGCCAGGTTCTTGATGT 
74 algI RT Forward CCTCTGCGTGCTCGGGTACT 
75 algI RT Reverse GATGTGGGTCAGCACGAACG 
80 algA RT Forward CCATGATGATCGCCCACAAG 
81 algA RT Reverse ACCTCGCAGTGGTTCTGGGT 
108 algG RT Forward CGCGACAACATCGTCTACGG 
109 algG RT Reverse TGATGCCGTGCTTCTTCCTG 
   
 
  
29 
 
Real-time polymerase chain reaction 
Complimentary DNA (cDNA) for use in real-time polymerase chain reaction (RT-PCR) 
was made from previously isolated RNA samples using Applied Biosystems™’ TaqMan
®
 
Reverse Transcription Reagents according to the manufacturer’s protocol.  In brief, the following 
were combined for a 50 µl reaction: 5 µl 10X TaqMan RT Buffer, 11 µl 25mM magnesium 
chloride, 10 µl dNTP mixture (10 mM per dNTP), 0.5 µl gene specific reverse primer (50 µM), 1 
µl RNase Inhibitor, 1.25 µl Multiscribe Reverse Transcriptase (50 U/µl) (except for no reverse 
transcriptase controls), 0.75 µg RNA, and RNase-free water to make 50 µl total volume.  
Reverse transcription was performed in a PTC-200 Peltier thermal cycler (MJ Research) using 
the following parameters: 10 minutes at 25°C, 30 minutes at 48°C, and 5 minutes at 95°C. 
 Specificity of gene specific primers and absence of contaminating DNA was verified by 
PCR amplification of cDNA using gene specific primers, AmpliTaq
®
 DNA polymerase (Applied 
Biosystems), and standard PCR cycling parameters.  PCR reactions were fractionated on 1% 
agarose gels and examined for appropriately sized single bands for reactions using gene specific 
primers or for no bands in the no reverse transcriptase controls.   
Following verification, gene specific cDNA was used in RT-PCR temperature gradients 
to determine primer efficiencies for each gene of interest. RT-PCR was performed using the 
MyiQ2 Two-Color Real-Time PCR Detection System (Bio-Rad) and SensiMix™ Plus SYBR & 
Fluorescein Kit (Quantace).  Serial dilutions of cDNA ranging from 50 ng to 6.25 ng were added 
to 12.5 µl SensiMix™, 2 µl gene specific forward primer (5 µM), 2 µl gene specific reverse 
primer (5 µM), and 6.5 µl water for a total volume of 25 µl.  Samples were processed in 96-well 
plates at a temperature range from 55-65°C with cycling parameters as follows:  3 minutes at 
95°C once; 10 seconds at 95°C, 30 seconds at 55-65°C, and 15 seconds at 72°C repeated 40 
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times; and 15 seconds at 55-95°C in 0.5 degree increments (to generate melt curve) once.  Real-
time PCR was then performed on each gene in triplicate based on the optimum efficiency 
determined by the temperature gradients using 6.25ng of cDNA and the cycling parameters 
outlined above.  Primer efficiencies ranged from 91.1 to 103.6. 
 
Construction of reporter fusion plasmids for use in beta-galactosidase assays 
Multiple strategies were employed in the construction of the strains used in the beta-
galactosidase assays based on the size of the region to be examined and availability of previously 
generated constructs.   
For the genes algG, algX, algJ, and algF, in which the area to be investigated was 
approximately 100 base pairs in size, oligonucleotides were constructed by Integrated DNA 
Technologies, Inc. identical to the sequences 100 base pairs upstream of the genes.  The 5’ end 
of the forward strands were engineered to include aatt overhangs and the 5’ end of the reverse 
strands to include gatc overhangs so that when annealed together the double-stranded 100 bp 
fragments would contain overhangs complimentary to DNA digested with EcoRI and BamHI 
restriction enzymes.   
The eight four nanomole oligonucleotides were resuspended in Milli-Q ultrapure water to 
yield a concentration of 1µg/µl.  Complimentary oligonucleotides were annealed by heating at 
85°C for 3 minutes in a 50 µl annealing reaction and then allowing them to cool very slowly over 
approximately 1.5 hours.  The annealing reaction included 2 µl forward oligonucleotide, 2 µl 
reverse oligonucleotide, 5 µl 10X annealing buffer (1 ml 1M Tris, 2 ml 5M NaCl, 200 µl 0.5M 
EDTA, and 6.8 ml Milli-Q water) and 41 µl Milli-Q water.  Successful annealing of the pairs 
was verified by side-by-side visualization of ethidium bromide stained single-strand and 
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annealed oligonucleotides on a 1% agarose gel.  Annealed oligonucleotides were ligated into 
plasmid pSS269 (isolated and purified from strain JLP149) digested with restriction enzymes 
EcoRI-HF and BamHI-HF in a 20 µl overnight reaction at 16°C as follows: 0.5 µl annealed 
oligonucleotide algG, algX, algJ, or algF; 1 µl pSS269 (2 µl for algG oligonucleotide); 1 µl T4 
DNA Ligase (New England Biolabs); 2 µl 10X T4 DNA Ligase Reaction Buffer; and 15.5 µl 
Milli-Q water (14.5 µl for algG oligonucleotide).  Ligation reactions were transformed into 
Subcloning Efficiency™ DH5α™ Competent Cells from Invitrogen following the standard 
manufacturer’s protocol.  In brief, 2.5 µl of individual ligation reactions were gently mixed into 
50 µl of DH5α cells that had been thawed on ice.  Reactions were incubated on ice for 30 
minutes and then cells were heat shocked for 20 seconds in a 42°C water bath.  Cells were 
returned to ice for two minutes, 950 µl of Luria-Bertani media was added, and cells were 
allowed to recover for one hour at 37°C with shaking.  Cells were then plated on Luria-Bertani 
plates with ampicillin (100 µg/ml) and incubated overnight at 37°C.  Colonies were screened by 
PCR to confirm the presence of the appropriate insert.  Successful ligations and transformations 
for algG, algX, algJ and algF upstream regions resulted in plasmids pJP16, pJP17, pJP18, and 
pJP19, and E. coli strains JLP159, JLP170, JLP167, and JLP165, respectively. 
To amplify the upstream region of the algI gene, primers were designed with an EcoRI 
restriction site at the 5’ end of the forward strand (Primer 92) and a BamHI restriction site at the 
5’ end of the reverse strand (Primer 93) (Table 3).  Primers were designed to amplify 
approximately 250 base pairs upstream of the start of the algI coding region and were used in a 
PCR reaction using Phusion High-Fidelity DNA Polymerase (Finnzymes) and Pseudomonas 
aeruginosa FRD1 cells to amplify the specified regions with EcoRI and BamHI restriction sites.  
The reaction was fractionated on a 1% agarose gel and a band of the appropriate size was excised 
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and purified using the QIAquick Gel Extraction Kit by Qiagen.  The manufacturer’s protocol for 
gel purification using a microcentrifuge was followed.  Once purified, the product was 
sequentially digested using BamHI-HF then EcoRI-HF high fidelity restriction enzymes from 
New England Biolabs.  In brief, 4 µl NEB Buffer #4, 10 µl purified PCR product, 1 µl BamHI-
HF, and 24 µl Milli-Q were incubated for one hour at 37°C.  An additional 1 µl BamHI-HF was 
added and the reaction was incubated another hour at 37°C.  The digestion was fractionated on a 
1% agarose gel, excised, and purified using the above referenced Qiagen kit.  A second digest 
was performed on the purified sample as previously outlined, using EcoRI-HF in place of 
BamHI-HF.  After purification, the algI upstream fragment was ligated into pSS269 and 
transformed into DH5α cells as outlined previously for upstream regions of algG, algX, algJ, and 
algF, with the exception of the amounts of insert, vector, and water used in the ligation reaction 
(1 µl algI insert, 2 µl pSS269, 14 µl Milli-Q).  Successful ligation and transformation for the algI 
upstream region resulted in plasmid pJP20, and E. coli strain JLP162. 
The E. coli DH5α strain LW1569 containing the plasmid pLW149a was previously 
created in the Ohman lab by ligating the region upstream of algD (approximately 930 base pairs) 
into the SmaI site of plasmid pSS269.  No manipulation of this construct was required before 
conjugation of the plasmid into the P. aeruginosa FRD1 strain. 
Transfer of the pSS269 plasmid constructs into the P. aeruginosa FRD1 strain (JLP7) 
was accomplished by conjugation.  E. coli strain JLP3 containing the helper plasmid pRK2013 
was used to facilitate the conjugation.  Cultures of FRD1, JLP3, and JLP159 (algG upstream), 
JLP170 (algX upstream), JLP167 (algJ upstream), JLP165 (algF upstream), JLP162 (algI 
upstream), and LW1569 (algD upstream) were started from individual colonies and incubated in 
Luria-Bertani (LB) media, with antibiotics where appropriate, at 37°C with shaking.  After 
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overnight incubation, 60 µl of the E. coli donor cultures (JLP159, JLP170, JLP167, JLP165, 
JLP162, and LW1569) were sub-cultured into 3 ml of fresh LB media with 100 ug/ml ampicillin.  
For each conjugation, 60 µl of JLP3 (helper culture) was sub-cultured into 3 ml of fresh LB 
media supplemented with 30 µg/ml kanamycin.  Both the donor and the helper sub-cultures were 
incubated at 37°C with shaking for approximately five hours.  For the recipient FRD1 strain 
(JLP7), one milliliter of overnight culture was combined with one milliliter of fresh LB media 
and 40 µl of 1 M NaNO3 for each conjugation and incubated without aeration for approximately 
5 hours at 37°C.  After incubation, 500 µl FRD1 recipient strain was combined with 600 µl JLP3 
helper strain and 600 µl of each donor strain (JLP159, JLP170, JLP167, JLP165, JLP162, and 
LW1569) were combined and cells were pelleted by centrifugation in a microcentrifuge at 
>13,000 rpm for three minutes.  Supernatant was removed, cells were washed with 500 µl of 
saline, and centrifuged again at >13,000 rpm for three minutes.  Cells were then resuspended in 
30 µl of saline, spotted on a Luria agar plate, and incubated at 30°C.  After overnight incubation, 
the cells were resuspended in three milliliters of saline and varying dilutions were spread on 
plates of ½ Pseudomonas Isolation Agar (PIA) and Luria agar supplemented with 150 µg/ml of 
carbenicillin.  Plates were incubated overnight at 37°C and any resulting conjugants were re-
streaked on fresh ½ PIA and Luria plates with carbenicillin to confirm uptake of the plasmid.  
Successful conjugations resulted in the following FRD1 strains carrying the pSS269 plasmid 
constructs:  JLP173 (algG upstream), JLP184 (algX upstream), JLP179 (algJ upstream), JLP182 
(algF upstream), JLP162 (algI upstream), and JLP196 (algD upstream). 
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Beta-galactosidase assay 
Overnight cultures of each strain containing upstream gene sequences in plasmid pSS269 
were grown in Luria-Bertani media and then subcultured at a ratio of 1:100 into fresh media and 
grown to an O.D.600 of approximately 0.8.  One hundred microliters of cell culture was added to 
900 µl of Z buffer (0.06M Na2HPO4, 0.04M NaH2PO4 · H2O, 0.01M KCl, 0.001M MgSO4 · 
7H2O, 0.05M β-mercaptoethanol), 20 µl 0.1% SDS, and 40 µl CHCl3 and vortexed to 
permeabilize cells.  Cells were incubated 5 minutes in a 28°C water bath with periodic vortexing.  
Following incubation, 200 µl of 4mg/ml o-nitrophenyl-beta-D-galactopyranoside (ONPG) in Z 
buffer was added to cells, cells were vortexed, and timing was started.  Five hundred microliters 
of stop solution (1M Na2CO3) was added upon the cell mixture turning a light yellow or at 30 
minutes, whichever occurred first.  The cell mixture was allowed to rest at 28°C for the CHCl3 to 
settle and 1 ml of the mixture was removed and absorbance at OD420 and OD550 was read.  Blank 
samples consisted of all components except cells and CHCl3.  Results were reported in Miller 
units calculated using the formula 1000 x [OD420 – (1.75 x OD550)]/[time (minutes) x volume 
(ml) x OD600] where time was equal to the minutes it took the reaction to occur and volume was 
equal to the amount of cell culture added to the reaction. 
 
5’ Rapid Amplification of cDNA Ends (5’ RACE) 
The 5’ RACE technique was chosen to determine the mRNA start site of the promoter 
regions upstream of the algG and algI alginate biosynthesis genes.  For this purpose the 
SMARTer™ RACE cDNA Amplification Kit was purchased from Clontech. 
5’ RACE-ready complimentary DNA (cDNA) was made using the SMARTer™ RACE 
kit according to the manufacturer’s protocol.  This process adds an extended tail at the 5’ end of 
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the cDNA that enables amplification using a Universal Primer Mix included in the SMARTer™ 
RACE kit.  The reverse algG and algI primers used for the real-time PCR analysis were used to 
generate the 5’ RACE-ready cDNA instead of the Random Primer Mix or CDS Primers (for use 
with RNA possessing poly A tails) included in the kit. 
After the generation of RACE-ready cDNA, 5’RACE was performed according to the 
manufacturer’s protocol.  As Advantage
®
-GC 2 Polymerase Mix was used for this process 
instead of Advantage
®
 2 PCR Mix, some modification of the protocol was necessary to allow for 
use of this polymerase.  Resulting reactions were fractionated on a 1% agarose gel, excised and 
purified using the QIAquick Gel Extraction Kit (Qiagen). 
The TOPO TA Cloning
®
 kit was used to ligate the purified DNA into the pCR
®
2.1-
TOPO vector and transform the reaction into One Shot
®
 TOP10 cells.  Transformants were 
selected by plating on Luria-Bertani plates with ampicillin (100 µg/ml) and X-gal (40 mg/ml).  
Seven colonies were selected and cultured in Luria-Bertani broth with ampicillin overnight at 
37°C with shaking.  Plasmids were isolated and purified then submitted to Eurofins MWG 
Operon (Huntsville, AL) for sequencing of the inserts. 
 
Modification of Strep-II tag® vector pASK-IBA63b for use in Pseudomonas 
The vector pASK-IBA63b-plus was purchased from IBA GmbH and altered for use in 
Pseudomonas.  Purified plasmid was transformed into E. coli DH5α cells following a standard 
protocol.  In brief, 0.5 µl of pASK-IBA63b-plus plasmid was gently mixed into 100 µl of DH5α 
cells that had been thawed on ice.  Reaction was incubated on ice for 45 minutes and then cells 
were heat shocked for 40 seconds in a 42°C water bath.  Cells were returned to ice for one 
minute, 600 µl of Luria-Bertani media was added, and cells were allowed to recover for one hour 
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at 37°C with shaking.  Cells were then plated on Luria-Bertani plates with ampicillin (100 
µg/ml) and incubated overnight at 37°C.  A colony was selected from the resulting 
transformants, re-streaked, cultured in liquid media, and frozen at -80°C as strain JLP30.  
Plasmid was isolated from an overnight JLP30 culture using the QIAprep® Miniprep Kit 
(Qiagen) and digested with SpeI restriction enzyme (New England Biolabs) as follows:  20 µl of 
pASK-IBA63b vector, 5 µl NEB Buffer #2, 3 µl SpeI, and 3 µl Milli-Q, incubated for three 
hours at 37°C.  The digestion reaction was then fractionated on an agarose gel, verified for 
digestion by comparison against uncut plasmid, excised, and purified using QIAEX II Gel 
Extraction Kit (Qiagen). 
Strain JLP33 was cultured overnight and the P. aeruginosa oriT -containing plasmid 
pSS125 was isolated and purified.  Purified pSS125 was digested with BamHI restriction enzyme 
(as outlined above for SpeI digestion of pASK-IBA63b vector) then fractionated, verified, 
excised and purified.  Both the digested pASK-IBA63b vector and the oriT fragment were 
treated with DNA Polymerase I, Large (Klenow) Fragment (New England Biolabs) to generate 
blunt ends.  In brief, 20 µl of vector or oriT fragment, 3 µl NEB Buffer #2, 1 µl Klenow, 4 µl 
0.25 mM dNTPs, and 2 µl Milli-Q, were incubated for 15 minutes at 25°C, and then the reaction 
was stopped by the addition of 0.6 µl 0.5 M EDTA and incubation at 75°C for 20 minutes.  The 
reactions were fractionated on an agarose gel, excised, and purified before ligation. 
The oriT fragment was ligated into pASK-IBA63b in a standard ligation reaction using 
T4 DNA ligase (New England Biolabs) and transformed into chemically compentent E. coli 
DH5α cells.  Cells were plated on Luria-Bertani plates with ampicillin (100 µg/ml) and 
incubated overnight at 37°C.  Resulting colonies were screened by PCR to confirm the presence 
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of the oriT insert.  Successful ligation and transformation for oriT in pASK-IBA63b resulted in 
plasmid pJP2 and E. coli strain JLP35. 
Plasmid was isolated from an overnight JLP35 culture and digested with NaeI restriction 
enzyme (New England Biolabs) in a standard reaction.  The digestion reaction was then 
fractionated on an agarose gel, verified for digestion by comparison against uncut pJP2 plasmid, 
excised, and purified. 
Strain JLP32 was cultured overnight and plasmid pSS124 containing the P. aeruginosa 
mini stabilizing fragment (mSF) was isolated and purified.  Purified pSS124 was digested with 
SphI restriction enzyme in a standard reaction then fractionated on an agarose gel, verified for 
digestion by comparison against uncut pSS124 plasmid, excised, and purified. 
The digested mSF fragment was treated with DNA Polymerase I, Large (Klenow) 
Fragment (New England Biolabs) as previously outlined to generated blunt ends.  The reaction 
was fractionated on an agarose gel, excised, and purified before ligation. 
A standard ligation of mSF and pJP2 was performed and transformed into chemically 
competent DH5α cells.  Cultures of the resulting colonies were examined for insertion of the 1.2 
kb mSF by a ‘Quick-Check’ method [57].  Briefly, 25 µl phenol, 25 µl chloroform, and 10 µl 
loading dye were combined in a microcentrifuge tube.  One hundred microliters of the 
transformant E. coli culture was added and the mixture was vortexed for 10 seconds.  Mixtures 
were spun for 3 minutes in a microcentrifuge at >13,000 rpm to fractionate.  Thirty microliters of 
the supernatant was loaded into an agarose gel and fractionated along with uncut pJP2 plasmid 
for size comparison purposes.  Plasmid containing the insert was designated pJP5 and the E. coli 
strain containing it was designated JLP43. 
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The algF coding region was amplified from FRD1 using Primers 16 and 17 to generate 
BspHI and XhoI restriction sites flanking the gene.  The resulting PCR product was digested 
with BspHI and XhoI in a standard digestion reaction, fractionated, and purified. 
Plasmid pJP5, isolated and purified from an overnight culture of JLP43, was digested 
with restriction enzymes NcoI and XhoI.  Following purification, digested pJP5 and BspHI and 
XhoI digested algF were combined in a standard overnight ligation reaction.  Chemically 
compentent E. coli DH5α cells were transformed with the ligation reaction and cells were plated 
on Luria-Bertani plates with ampicillin (100 µg/ml) and incubated overnight at 37°C.  Resulting 
colonies were screened by the Quick-Check method and by PCR to confirm the presence of the 
algF insert.  Successful ligation and transformation of algF into pJP5 resulted in plasmid pJP11 
and E. coli strain JLP65. 
Transfer of the pJP11 plasmid construct into the P. aeruginosa FRD1 and FRD1175 
(ΔalgF) strains was accomplished by conjugation.  E. coli strain JLP3 containing the helper 
plasmid pRK2013 was used to facilitate the conjugation.  Cultures of FRD1, FRD1175, JLP3, 
and JLP65 were started from individual colonies and incubated in Luria-Bertani (LB) media, 
with antibiotics where appropriate, at 37°C with shaking.  After overnight incubation, 60 µl of 
the E. coli donor culture (JLP65) was sub-cultured into 3 ml of fresh LB media with 100 ug/ml 
ampicillin, and 60 µl of JLP3 (helper culture) was sub-cultured into 3 ml of fresh LB media 
supplemented with 30 µg/ml kanamycin.  Both the donor and the helper sub-cultures were 
incubated at 37°C with shaking for approximately five hours.  For the recipient FRD1 and 
FRD1175 strains, one milliliter of overnight culture was combined with one milliliter of fresh 
LB media and 40 µl of 1M NaNO3 and incubated without aeration for approximately 5 hours at 
37°C.  After incubation, 500 µl of each FRD recipient strain (FRD1 and FRD1175) was 
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combined with 600 µl JLP3 helper strain and 600 µl of the donor strain (JLP65) and cells were 
pelleted by centrifugation in a microcentrifuge at >13,000 rpm for three minutes.  Supernatant 
was removed, cells were washed with 500 µl of saline, and centrifuged again at >13,000 rpm for 
three minutes.  Cells were then resuspended in 30 µl of saline, spotted on a Luria agar plate, and 
incubated at 30°C.  After overnight incubation, the cells were resuspended in three milliliters of 
saline and varying dilutions were spread on plates of ½ Pseudomonas Isolation Agar (PIA) and 
Luria agar supplemented with 150 µg/ml of carbenicillin.  Plates were incubated overnight at 
37°C and any resulting conjugants were re-streaked on fresh ½ PIA and Luria plates with 
carbenicillin to confirm uptake of the plasmid.  Successful conjugation resulted in the P. 
aeruginosa strains JLP98 (FRD1 with algF Strep-II tag expressed in trans from plasmid pJP11) 
and JLP113 (FRD1175 ΔalgF strain with algF Strep-II tag expressed in trans from plasmid 
pJP11). 
 
AlgF-Strep-II tagged protein induction and purification 
 The optimal growth point for maximum induction of AlgF-Strep-II tagged proteins was 
determined empirically to be at an OD600 of 0.2.  Bacterial cultures to be induced were sub-
cultured from overnight cultures at a ratio of 1:100 and incubated at 37°C with shaking until the 
optimum OD was reached.  Protein expression was induced by addition of 0.1 µl of 
anhydrotetracyline (aTc) per 1 ml of culture.  Incubation with shaking was continued for three 
hours then cells were harvested by centrifugation at 10,000 x g at 4°C and cell pellets were 
frozen overnight before purification.  Bugbuster® HT Protein Extraction Reagent (Novagen) was 
used for cell lysis according to the manufacturer’s protocol. 
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 Following lysis AlgF-Strep-II tagged proteins were purified by gravity-flow column 
chromatography using Strep-Tactin sepharose resin and following the manufacturer’s protocol.  
Buffers for protein purification as well as anhydrotetracyline for protein induction were 
purchased from IBA BioTAGnology. 
 
SDS-PAGE 
 Various purified bacterial proteins and bacterial culture lysates were subjected to sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for analysis.  Samples were 
loaded into either precast Criterion Tris-HCL polyacrylamide gels (Bio-Rad) or polyacrylamide 
gels were cast as outlined below. 
 Large 12% polyacrylamide gels were prepared by mixing 12.2 ml Milli-Q water, 8.75 ml 
4X Separating Buffer (1.5 M Tris-HCl, 0.4% SDS, pH 8.8), and 14.0 ml 30% acrylamide. Two 
hundred fifty microliters 10% ammonium persulfate and 10 µl TEMED were added, mixed by 
swirling, and poured between clamped glass plates.  Milli-Q water was slowly layered on top of 
acrylamide mixture and gel was allowed to polymerize.  Water was removed and a stacking gel 
composed of 9 ml Milli-Q water, 3.75 ml 4X Stacking Buffer (0.5 M Tris-HCl, 0.4% SDS, pH 
6.8), 1.95 ml 30% acrylamide, 200 µl 10% ammonium persulfate, and 10 µl TEMED was added 
with an appropriate comb. 
 Samples were typically loaded with a 2X reducing (0.125 M Tris-HCl pH 6.8, 4% SDS, 
5% β-mercaptoethanol, 20% glycerol, and 0.2% bromophenol blue) or non-reducing buffer 
(0.125 M Tris-HCl pH 6.8, 4% SDS, 20% glycerol, and 0.2% bromophenol blue) depending on 
the application, and Precision Plus Protein Dual Color Standards (Bio-Rad) were used for 
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molecular weight estimation.  SDS-PAGE gels were typically electrophoresed at 200 volts for 
50-60 minutes. 
 
Immunoblot analysis 
 After bacterial proteins or bacterial cell lysates were subjected to sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE), samples were transferred to polyvinylidene 
difluoride (PVDF) membrane (Immun-Blot PVDF Membrane, Bio-Rad).  Before alignment with 
the polyacrylamide gel, the PVDF membrane was wet using 100% methanol and then 
equilibrated in transfer buffer for approximately 5 minutes.  Transfer to the membrane was 
typically accomplished by applying 100 volts for approximately one hour using a tank transfer 
system. 
 After transfer, membranes were blocked in Tris-buffered saline (TBS) with 0.5 % Tween 
and 0.5 % bovine serum albumin (BSA) overnight at 4°C or for at least one hour at room 
temperature with rocking.  For Strep-II tagged proteins, primary antibody was typically used at a 
1:2000 concentration (IBA) in blocking buffer (TBST with BSA) when using a goat anti-mouse 
HRP-conjugated secondary antibody, and a 1:10,000 concentration when using a rabbit anti-
mouse horseradish peroxidase (HRP)-conjugated secondary antibody.  Typical primary antibody 
incubation was one hour at room temperature with rocking.  Membranes were washed three 
times with TBST for 10 – 15 minutes each after incubation with primary antibody for one hour 
with rocking.  Secondary antibody was added at a concentration of 1:40,000 and membranes 
were incubated for one hour at room temperature with rocking.  After removal of secondary 
antibody, membranes were washed three times and SuperSignal West Pico Chemiluminescent 
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Substrate (Pierce) was added for five minutes with rocking.  Reactive proteins were visualized 
by exposure of the membrane to x-ray film for variable lengths of time. 
 
2-D Redox SDS-PAGE 
 Affinity purified AlgF-Strep-II tagged protein was separated by SDS-PAGE on a 12% 
polyacrylamide gel in the first dimension using non-reducing buffer.  The lane was excised and 
soaked in 2X reducing SDS buffer with shaking for 30 minutes.  (An identical lane was also 
excised but left in buffer until the staining process.)  The polyacrylamide strip (gel lane) was 
rinsed with running buffer and loaded into a large well in a second polyacrylamide gel (either 
12% or 10-20% gradient).  The gel was run as normal with proteins moving from the gel strip in 
the well into the second gel. 
 When the dye front reached the bottom of the gel, current was discontinued and the 
separating gel and identical gel strip saved from the first gel were stained using the Bio-Rad 
Silver Stain Plus Kit according to the manufacturer’s protocol. 
 
Protein identification by mass spectrometry analysis 
 Eight identical 2-D Redox SDS-PAGE gels of purified AlgF-Strep-II tagged protein were 
run and stained with mass spectrometry compatible SilverSNAP Silver Stain Kit II (Pierce).  
After gels were washed overnight in Milli-Q water, three select protein spots from each gel were 
excised, pooled and then treated with a reduction/alkylation procedure to increase peptide 
recovery (Nature Protocols, 1 (6), 2856 – 2860, 2006).  Pooled gel slices were placed in a 
microcentrifuge tube and 500 µl of acetonitrile was added.  Slices were incubated at room 
temperature for 10 minutes and then spun in a microcentrifuge to allow removal of the liquid.  
43 
 
Fifty microliters of 10 mM DTT in 100 mM ammonium bicarbonate was added and the samples 
were incubated for 30 minutes at 56°C.  Samples were allowed to cool to room temperature and 
500 µl of acetonitrile was added.  After 10 minute room temperature incubation, samples were 
spun and liquid was removed.  Fifty microliters of 55 mM iodoacetamide in 100 mM ammonium 
bicarbonate was added and the samples were incubated at room temperature for 20 minutes in 
the dark.  The iodoacetamide solution was removed and the gel slices were incubated in 500 µl 
of acetonitrile.  Samples were spun to remove liquid and 100 µl of a 1:1 (volume/volume) 100 
mM ammonium bicarbonate/acetonitrile mixture was added.  Samples were incubated for 30 
minutes with occasional vortexing.  Five hundred µl of acetonitrile was added and samples were 
incubated at room temperature with occasional vortexing until gel slices became white and 
shrunk.  Samples were spun in a microcentrifuge, liquid was removed and samples were stored at 
-20°C until shipping. 
 Samples were submitted to Applied Biomics, Hayward, California, for protein 
identification by mass spectrometry analysis. 
 
Construction of algF C194S plasmid  
The algF coding sequence was amplified in two portions by overlap extension 
polymerase chain reaction from the P. aeruginosa FRD1 strain using primers 50 and 53, and 
primers 51 and 52 (Table 3).  Phusion™ High-Fidelity DNA Polymerase (Finnzymes/New 
England Biolabs) with GC buffer was used to amplify the products following the manufacturer’s 
recommended PCR protocol.  Use of Phusion™ polymerase results in a blunt end PCR product 
which can be ligated directly into a SmaI digested vector.  Primers 50 and 51 anneal to sequences 
approximately 800 bp upstream of the beginning of the algF gene and 800 bp downstream of the 
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end of the gene, respectively, to allow for recombination into the genome.  Primers 51 and 52 are 
overlapping reverse complement primers containing mutations at the sequence encoding amino 
acid 194.  The sequence was engineered to alter one nucleotide in the codon 194 sequence from a 
G to a C resulting in the triplet TCC, coding for serine, instead of TGC encoding cysteine.  After 
amplification the PCR products were fractionated on a 1% agarose gel, excised, and purified 
using the QIAquick Gel Extraction Kit by Qiagen.  The manufacturer’s protocol for gel 
purification using a microcentrifuge was followed.  Another PCR reaction was performed to 
amplify the entire mutagenized algF coding region using a mixture of the purified PCR reactions 
containing the two mutagenized portions of the algF gene as template and phosphorylated 
primers 82 and 83 (identical to primers 50 and 51 but engineered with added phosphates).  The 
PCR reaction was fractionated on a 1% agarose gel, excised, and purified. 
Plasmid pUC19 was purified from E. coli strain JLP54 using the QIAprep® Miniprep Kit 
(Qiagen) according to the manufacturer’s protocol and the purified plasmid was digested using 
the SmaI restriction enzyme from New England Biolabs in a typical digestion reaction.  The 
digestion reaction was then fractionated on an agarose gel, verified for digestion by comparison 
against uncut plasmid, and excised and purified.  The digested plasmid was then treated with 
Antarctic Phosphatase (New England Biolabs) to dephosphorylate the vector in a reaction 
including 20 µl pUC19, 2.3 µl 10X Antarctic Phosphatase Reaction Buffer, and 1 µl 
phosphatase.  The reaction was incubated 15 minutes at 37°C and then heat inactivated by 
incubation for 5 minutes at 65°C.  
The purified algF C194S fragment was ligated into digested, dephosphorylated pUC19 
plasmid in a 20 µl overnight reaction at 16°C as follows: 4 µl purified algF C194S, 1 µl pUC19, 
1 µl T4 DNA Ligase (New England Biolabs); 2 µl 10X T4 DNA Ligase Reaction Buffer; and 12 
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µl Milli-Q water.  Ligation reactions were transformed into Subcloning Efficiency™ DH5α™ 
Competent Cells (Invitrogen) as follows:  2.5 µl of ligation reaction was gently mixed into 50 µl 
of DH5α cells that had been thawed on ice.  Reaction was incubated on ice for 30 minutes and 
then cells were heat shocked for 20 seconds in a 42°C water bath.  Cells were returned to ice for 
two minutes, 950 µl of Luria-Bertani media was added, and cells were allowed to recover for one 
hour at 37°C with shaking.  Cells were then plated on Luria-Bertani plates with ampicillin (100 
µg/ml) and incubated overnight at 37°C.  Resulting colonies were screened by the Quick-Check 
method [57] and PCR to confirm the presence of the algF C194S insert.  Successful ligation and 
transformation for algF C194S in pUC19 resulted in plasmid pJP21 and E. coli strain JLP150. 
To move the algF C194S fragment from pUC19 to pEX18Ap, a non-replicative plasmid 
designed for use in Pseudomonas, plasmid pJP21 was isolated from strain JLP150 and digested 
with BamHI-HF and EcoRI-HF high fidelity restriction enzymes from New England Biolabs.  
Plasmid pEX18Ap was isolated from strain JLP148 and digested with these same restriction 
enzymes in a standard double digest reaction.  In brief, 4 µl NEB Buffer #4, 10 µl purified 
pEX18Ap plasmid, 1 µl BamHI-HF, 1 µl EcoRI-HF, and 22 µl Milli-Q were incubated for one 
hour at 37°C.  An additional 1 µl BamHI-HF and 1 µl EcoRI-HF were added and the reaction 
was incubated another hour at 37°C, for a total incubation time of two hours.  The digestion 
reactions were fractionated on a 1% agarose gel and the appropriate products were excised and 
then purified using the QIAquick Gel Extraction Kit by Qiagen. 
The purified algF C194S fragment was ligated into plasmid pEX18Ap in a standard 20 µl 
overnight ligation reaction at 16°C using 1 µl of pEX18Ap and 8 µl of the insert.  Subcloning 
Efficiency™ DH5α™ Competent Cells (Invitrogen) were transformed with the ligation reaction 
as outlined above.  Resulting colonies were screened by PCR to confirm the presence of the algF 
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C194S insert.  Successful ligation and transformation for algF C194S in pEX18Ap resulted in 
plasmid pJP22 and E. coli strain JLP153. 
To verify that the sequence encoding amino acid 194 in algF had been mutated from 
TGC to TCC and that there were no other unintentional mutations in the coding sequence, strain 
JLP153 was cultured overnight and plasmid pJP22 was purified for sequencing using the 
QIAprep® Miniprep Kit (Qiagen).  Sequencing was performed by Eurofins MWG Operon 
(Huntsville, AL) and confirmed the presence of the engineered algF C194S mutation.  Other 
sequence differences identified did not result any change in amino acid sequence between the P. 
aeruginosa FRD1 algF sequence and the published P. aeruginosa PAO1 sequence. 
Transfer of the pEX18Ap plasmid construct into the P. aeruginosa ΔalgF strain 
FRD1175 by conjugation was then attempted as follows.  Cultures of FRD1175, JLP3 
(containing the helper plasmid pRK2013), and JLP153 were started from individual colonies and 
incubated in Luria-Bertani (LB) media, with antibiotics where appropriate, at 37°C with shaking.  
After overnight incubation, 60 µl of the E. coli donor culture (JLP153) was sub-cultured into 3 
ml of fresh LB media with 100 ug/ml ampicillin, and 60 µl of JLP3 (helper culture) was sub-
cultured into 3 ml of fresh LB media supplemented with 30 µg/ml kanamycin.  Both the donor 
and the helper sub-cultures were incubated at 37°C with shaking for approximately five hours.  
For the recipient FRD1ΔalgF strain FRD1175, one milliliter of overnight culture was combined 
with one milliliter of fresh LB media and 40 µl of NaNO3 and incubated without aeration for 
approximately 5 hours at 37°C.  After incubation, 500 µl of the FRD1175 recipient strain, 600 µl 
of the JLP3 helper strain, and 600 µl of the donor strain (JLP153) were combined and cells were 
pelleted by centrifugation in a microcentrifuge at >13,000 rpm for three minutes.  Supernatant 
was removed, cells were washed with 500 µl of saline, and centrifuged again at >13,000 rpm for 
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three minutes.  Cells were then resuspended in 30 µl of saline, spotted on a Luria agar plate, and 
incubated at 30°C.  After overnight incubation, the cells were resuspended in three milliliters of 
saline and varying dilutions were spread on plates of ½ Pseudomonas Isolation Agar (PIA) and 
Luria agar supplemented with 150 µg/ml of carbenicillin.  Overnight incubation of the plates at 
37°C failed to result in any conjugants. 
Repeated attempts at conjugation of the pJP22 plasmid into P. aeruginosa using other 
proven conjugation protocols and other P. aeruginosa strains also proved unsuccessful. 
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Acetylation of Uronic Acids Produced by Alginate Biosynthesis Mutants 
 
Evaluation of uronic acid recovery techniques 
 Before analysis of alginate production in various P. aeruginosa strains, it was necessary 
to evaluate the available alginate recovery techniques currently in use.  The FRD1 strain was 
used as a positive control as it has been demonstrated to produce large amounts of alginate, and 
the FRD2 strain, a non-mucoid revertant of FRD1caused by an algT mutation, served as a 
negative control.  Other strains that produced intermediate levels of alginate or polymer of 
reduced length were analyzed to evaluate the effectiveness of the recovery techniques in these 
situations. 
 Initial uronic acid assays were performed using total supernatant isolated by 
centrifugation from overnight liquid cultures of P. aeruginosa FRD1, FRD2, and an algX mutant 
strain which produces only a very minimal amount of alginate.  While the supernatants from 
FRD1 and the algX mutant strain performed adequately in the assay, the supernatant isolated 
from the FRD2 culture resulted in a sample possessing a light brownish-peach color that 
produced an interfering spectrophotometry reading. 
 The above strains were then grown as lawns on solid media overnight at 37°C.  The 
bacterial cells along with any alginate produced were harvested by dilution with saline and 
manual scraping of the agar surface.  Cells were pelleted by centrifugation and a portion of total 
supernatant was used in the uronic acid assay.  While this method of alginate recovery resulted in 
appropriately colored samples for spectrophotometry, with little interfering color from the FRD2 
negative control strain, the efficiency of bacterial cell removal by centrifugation was somewhat 
reduced from that of broth cultures in strains producing large amounts of alginate. 
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 Another method sometimes used for the isolation of alginate from liquid cultures is 
precipitation by cetylpyridinium.  The procedure involves addition of 2% cetylpyridinium 
chloride to supernatants, followed by centrifugation and an additional isopropanol precipitation.  
Supernatants from cultures of the strains referenced above and an additional algG mutant strain 
which produces small alginate fragments were subjected to cetylpyridinium precipitation and the 
resulting re-suspended uronic acids were subjected to quantitation.  While samples from the 
FRD1 positive control strain and algX mutant strain possessed appropriate color and the FRD2 
negative control strain did not possess interfering color, there was no reaction for the algG 
mutant strain producing small alginate fragments.  This indicated that the small uronic acid 
fragments were not precipitated using this procedure. 
 Another precipitation method frequently used to isolate alginate is ethanol precipitation.  
Supernatants from cultures of the same strains tested using cetylpyridinium precipitation were 
subjected to ethanol precipitation using 2.5 volumes of 95% ice cold ethanol as outlined in the 
Materials and Methods section on alginate isolation and the re-suspended precipitates were  
assayed for uronic acid content.  Samples from the FRD1 positive control strain and the 
intermediate alginate producing algX mutant strain produced appropriate colors in the assay and 
the FRD2 negative control strain sample did not produce any interfering color.  The sample from 
the algG mutant strain which produces small alginate fragments tested positive for uronic acid 
indicating that the ethanol precipitation procedure successfully precipitated both polymer and 
small uronic acid fragments.  Given these results, ethanol precipitation from the supernatant of 
liquid culture was selected as the standard protocol for isolation of uronic acid.  Table 5 
summarizes the characteristics of the evaluated alginate recovery techniques.  
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Table 5.  Characteristics of alginate recovery techniques important to downstream applications  
Alginate Recovery Technique 
Component Used 
in Assay 
Interfering Color in 
Negative Control 
Isolation of 
Small Uronics 
Centrifugation of broth culture Supernatant Yes Yes 
Centrifugation of plate scrapes 
diluted in saline 
Supernatant No Yes 
Cetylpyridinium precipitation of 
broth culture supernatant 
Precipitates 
resuspended in 
saline 
No No 
Ethanol precipitation of broth 
culture supernatant 
Precipitates 
resuspended in H2O 
No Yes 
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Analysis of uronic acid acetylation in mutant strains 
 Over the last several years many alginate biosynthesis gene mutant strains have been 
developed to study the effect of non-polar insertional mutations, deletions, or point mutations on 
the production of alginate.  While the level of alginate production from these strains has been 
documented, the acetylation level of the alginate produced by these alginate biosynthesis mutants 
has not been examined. The purpose of this work was to determine the acetylation status of the 
alginate produced by these mutant strains and add to the current knowledge base regarding how 
alginate polymerization and acetylation are related [12, 15, 22, 27, 51]. 
 Seven alginate biosynthesis mutant strains were analyzed in this study, with this being the 
initial analysis of alginate acetylation status by this method for six of the seven strains.  Alginate 
from two algG mutant strains, FRD1200, an algG deletion mutant producing small uronic acids 
(<10,000 M.W.), and FRD462, a strain possessing a point mutation in algG and producing a 
polymannuronate alginate lacking guluronates, were assayed for acetyl group content [14] [27].  
The small uronic acids produced by the FRD1200 strain are believed to be products of alginate 
degradation by the alginate lyase encoded by the algL gene [27].  The amount of acetyl groups 
present in uronic acids from FRD1100, an algK deletion mutant demonstrating a non-mucoid 
phenotype and producing low levels of dialyzable uronic acid, was also determined [27, 58] [12].  
The remaining two published strains assayed were FRD1108 and FRD1144, an alg8 and an 
alg44 non-polar insertional mutant, respectively, both possessing a non-mucoid phenotype and 
negative for uronic acid production [22].  Uronic acids from an unpublished algX::Gm 
insertional mutant strain were also analyzed.  A similar construct was previously examined for 
uronic acid production and the phenotypically non-mucoid strain was determined to produce low 
levels of small uronic acids [15].  While the acetylation status of the alginate produced by 
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FRD1175, an algF deletion mutant demonstrated to produce wild-type levels of non-acetylated 
alginate, had been examined at the time the mutation was engineered, it was included in this 
study as additional verification of assay results and for comparative purposes [59].  Levels of 
uronic acid production and acetylation values for the mucoid CF strain FRD1 and its non-mucoid 
revertant, FRD2, were also determined in the study for use as positive and negative controls, 
respectively. 
 Uronic acids analyzed in this study were isolated by ethanol precipitation from overnight 
Luria-Bertani broth cultures, and the uronic acid and acetylation levels were determined by 
colormetric assays as outlined in the Materials and Methods section of this work.  The results of 
the uronic acid quantitation assay are presented in Figure 3. 
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Figure 3.  Levels of uronic acid produced by P. aeruginosa strains.  Data are shown as mean 
and standard deviation of a representative experiment carried out with technical triplicates.  
Asterisks represent a significant change in amount of uronic acid produced by indicated strains 
when compared to background levels found in the negative control strain FRD2 (P < 0.001, as 
determined by Student’s t-Test). 
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 As expected, the FRD1 positive control strain produced significant levels of alginate as 
determined by the assay.  The algF and two algG mutants also produced measurable amounts of 
uronic acid although not to the extent of that produced by FRD1.  The level of uronic acid 
produced by the alg8 mutant strain was the same as background levels detected in the FRD2 
negative control strain.  While the alg44 mutant strain showed a level of uronic acid production 
that was determined to be significantly increased above the FRD2 background level, the overall 
amount was extremely low.  The algX and algK mutant strains, which both possess a non-
mucoid phenotype, produced only low levels of uronic acids as measured in this assay. 
 Acetylation assay results are presented in Figure 4.  The assay was performed on aliquots 
of the same alginate solutions as used in the uronic acid assay. 
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Figure 4.  Levels of acetylation of uronic acids produced by P. aeruginosa strains.  Data are 
shown as mean and standard deviation of a representative experiment carried out with technical 
triplicates.  Uronic acid levels of all strains were normalized to FRD1 levels to allow for 
comparison of acetylation levels between strains.  Activity below that found in the FRD1175 
algF mutant strain, previously determined to produce un-acetylated polymer, was treated as 
background activity. 
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 Of the strains assayed, only the FRD1 positive control strain and the algG mutant strain 
FRD462 that had been shown to produce a polymannuronate polymer produced uronic acids that 
possessed levels of acetyl groups above background levels.  As the non-mucoid FRD2 strain and 
the alg8 mutant strain FRD1108 did not produce levels of uronic acid over background, any level 
of acetylation detected by the assay for these samples would be background activity only.  The 
other strains assayed, with mutations in algX, algG (FRD1200), and algK (FRD1100), did not 
produce uronic acids containing amounts of acetyl groups above the background levels found in 
the algF (FRD1175) acetylation-deficient strain. 
 The findings from both assays are summarized in Table 6. 
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Table 6.  Characteristics of select P. aeruginosa alginate biosynthesis mutant strains relating to 
uronic acid production 
Strain Mutation and 
affected Gene 
Gene 
Function 
Phenotype Uronic Acid 
Production 
Uronic Acid 
Acetylation 
FRD1175 ΔalgF Acetylation Mucoid Full-length 
polymer 
No 
FRD1200 ΔalgG Epimerization, 
Scaffold 
Non-mucoid Small uronic acids No 
FRD462 Point mutation 
algG4 
Epimerization, 
Scaffold 
Mucoid Full-length 
polymannuronate 
polymer 
Yes 
FRD1100 ΔalgK Scaffold Non-mucoid Small uronic acids No 
FRD1108 alg8::Gm Polymerization Non-mucoid None N/A 
FRD1144 alg44::Gm Polymerization Non-mucoid None N/A 
JLP4 algX::Gm Unknown Non-mucoid Small uronic acids No 
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Discussion 
 Based on the results of the acetylation assays of the P. aeruginosa alginate biosynthesis 
mutant strains studied in this work, and on information gathered from previous studies of the 
alginate produced by these strains, it can be concluded that the small, dialyzable uronic acids 
produced by the algX, algG, and algK alginate biosynthesis mutant strains are not acetylated.  
The algX, algG, and algK mutant strains produced different amounts of small uronic acids, but in 
all cases the amount of acetyl groups per microgram of uronic acid present in the sample was 
below background levels.  The lack of acetylation of the small uronic acids produced by the algX 
mutant strain in this study is in agreement with findings from the mass spectrometry analysis of 
the small oligouronides produced by a similar algX mutant strain in the work published by 
Robles-Price [15]. 
 This observation has important implications regarding the localization of the acetylation 
step in the formation of full-length, acetylated alginate polymer.  The lack of acetylation of small 
uronic acid fragments suggests that a polymer of some minimum length is necessary for 
acetylation to take place, supporting the hypothesis that alginate acetylation takes place in the 
periplasm and not in the cytoplasm where only non-polymerized, individual mannuronates would 
be present. 
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Involvement of the algX Alginate Biosynthesis Gene in Alginate Acetylation 
 
Confirmation of the non-polarity of an algX::Gm mutation 
 The alginate biosynthesis gene algX shares 30% identity with the alginate acetylation 
gene algJ, and has thus been postulated to play a role in the alginate acetylation process.  A 
strain bearing a non-polar algXΔ::Gm mutation was shown to be deficient in alginate polymer 
formation, producing and secreting small uronic acids instead, and suggesting a role in scaffold 
formation and not acetylation [15].  However, if the algX gene product plays a role in both 
acetylation and scaffold formation, a mutation of this type could obscure any effect of AlgX on 
acetylation.  An alternative strategy that could preserve the ability of AlgX to function in the 
scaffold and yet reveal any involvement in acetylation was developed based on the homology 
between the algX and algJ genes.  A histidine to alanine point mutation of amino acid 195 within 
a conserved motif present in AlgJ was shown to produce non-acetylated alginate when expressed 
in trans in an algJ deletion strain [60].  This same conserved motif is present in AlgX with the 
histidine residue located at position 176 (Figure 5). 
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Figure 5.  Partial protein sequence alignment of P. aeruginosa AlgJ and AlgX showing the 
conserved motif present in a subset of type II membrane proteins.  Amino acids highlighted 
in gray indicate conserved residues within the subset.  Positions are indicated above key residues. 
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AlgJ LAVIPAKA-------RTDTHWSPLG 
AlgX VVYQPTRG-------KGDHHWTPHG 
195 
176 
134 
113 
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 If AlgX is involved in alginate acetylation, the same mutation of this conserved histidine 
residue in AlgX may abolish acetylation but allow for production of alginate by preserving 
AlgX’s function within the scaffold.  An algX::Gm mutant strain, designated JLP4, was 
previously created in the Ohman lab, however, before it could be used in this study it was 
necessary to confirm that the gentamicin cassette insertion into algX was non-polar and that loss 
of the mucoid phenotype was not due to deleterious effects on downstream genes.  This was 
accomplished by providing algX in trans on plasmid pMF54 in the algX::Gm mutant strain and 
verifying restoration of the mucoid phenotype and production of acetylated alginate.  Generation 
of this algX::Gm complementation strain, JLP121, was accomplished as outline in the Materials 
and Methods section. 
 Overnight growth of P. aeruginosa strain JLP121 [FRD1algX::Gm(pJP12)] on Luria-
Bertani agar at 37°C resulted in colonies with a mucoid phenotype typical of the FRD1 parent 
strain.  Alginate was isolated from strain JLP121 and subjected to uronic acid and acetylation 
quantitation as outlined in the Materials and Methods section.  Results from the uronic acid and 
acetylation assays indicated no significant differences in alginate production or acetylation for P. 
aeruginosa JLP121 and FRD1 strains.  The ability of only AlgX provided in trans to complement 
the algX::Gm insertional mutant indicated that the mutation did not exert negative effects on 
downstream genes and would be suitable for further investigation into the role of AlgX in 
acetylation (Figures 6 and 7). 
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Figure 6.  Levels of uronic acid produced by P. aeruginosa strains FRD1 and algX 
complementation strain JLP121.  Data are shown as mean and standard deviation of three 
separate experiments.  There was no significant difference between the strains in amount of 
alginate produced (P < 0.001, as determined by Student’s t-Test). 
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Figure 7.  Levels of acetylation of uronic acids produced by P. aeruginosa strain FRD1 and 
algX complementation strain JLP121.  Data are shown as mean and standard deviation for 
three separate experiments.  There was no significant difference between the strains in acetyl 
groups per milligram of uronic acids for alginate produced (P < 0.001, as determined by 
Student’s t-Test). 
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Effect on acetylation of a mutation of a conserved amino acid in algX 
 To determine whether or not AlgX is involved in alginate acetylation in addition to its 
role as a scaffold protein, a site-directed mutation was made in the DNA sequence of the algX 
gene.  The mutation changed a conserved histidine residue at position 176 of the AlgX protein 
sequence to an alanine. This histidine residue is conserved in alginate acetylation protein AlgJ 
and other type II membrane proteins, as well as in AlgX which shares 30% identity with AlgJ.  
When this same mutation in AlgJ was expressed in trans from a plasmid in an algJ deletion 
strain it resulted in loss of alginate acetylation [60].  In order to test the effect of this mutation in 
AlgX on alginate acetylation, a plasmid expressing algX H176A was introduced into an 
algX::Gm strain as described in the Materials and Methods section, creating strain JLP135 
(Figure 8). 
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Figure 8.  Schematic representation of alginate biosynthesis algX gene H176A site-directed 
mutation and replicative plasmid pMF54.  Overlapping extension polymerase chain reaction 
was used to mutate two nucleotides, changing the codon at position 176 from CAC (histidine) to 
GCC (alanine).   Stabilizing fragment (S.F.) is required for replication of the plasmid in P. aeruginosa 
and oriT is required for conjugation into Pseudomonas. 
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 Overnight growth of this strain on Luria-Bertani agar at 37°C resulted in mucoid colonies 
indicating that the mutation did not disrupt alginate production.  The phenotype of this strain was 
indistinguishable from that of strain JLP121 expressing wild-type algX from the same plasmid in 
the algX::Gm strain (Figure 9). 
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Figure 9.  P. aeruginosa FRD1, JLP4, JLP121, and JLP135 strains after overnight growth 
on Luria-Bertani agar at 37°C.  Strains FRD1, JLP121, and JLP135 exhibit a mucoid 
phenotype while strain JLP4 does not. 
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 To verify alginate production and determine its level of acetylation, alginate was isolated 
from strain JLP135 and subjected to uronic acid and acetylation quantitation as outlined in the 
Materials and Methods section.  Results from the uronic acid and acetylation assays indicated no 
significant differences in alginate production or acetylation for P. aeruginosa JLP135 and 
JLP121, the strain expressing wild-type algX from plasmid pMF54 (Figures 10 and 11). 
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Figure 10.  Levels of uronic acid produced by P. aeruginosa strains JLP121 and algX 
H176A mutation strain JLP135.  Data are shown as mean and standard deviation of three 
separate experiments.  There was no significant difference between the strains in amount of 
alginate produced (P < 0.001, as determined by Student’s t-Test). 
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Figure 11.  Levels of acetylation of uronic acids produced by P. aeruginosa strain JLP121 
and algX H176A mutation strain JLP135.  Data are shown as mean and standard deviation for 
three separate experiments.  There was no significant difference between the strains in acetyl 
groups per milligram of uronic acids for alginate produced (P < 0.001, as determined by 
Student’s t-Test). 
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Discussion 
 The availability of the FRD1algX::Gm strain will facilitate further study of the role AlgX 
may play in alginate biosynthesis.  While this study indicates that AlgX is not involved in 
acetylation, it is possible that the histidine residue, while conserved between AlgX and AlgJ, is 
not a key residue for the function of AlgX.  The difference in amino acid sequence between the 
two indicates a different role for AlgX, and whether involved in acetylation or not, residues 
necessary for activity may lie elsewhere in the protein.  It is also possible that the neighboring 
histidine residue in algX (residue 175), not present in algJ, is able to compensate for the mutation 
of histidine 176 to an alanine.  Mutation of both residue 175 and 176 may be necessary to see an 
effect.  An avenue that might provide additional information about AlgX would be random 
mutagenesis of the algX coding region.  This may generate mutants with interesting phenotypes 
that could be further explored. 
 Aside from the obvious data garnered from these results, the sequencing of the algX gene 
provided more subtle insight into the sequence of FRD1.  The number of base pair differences 
between the sequence of algX and the published sequence for PAO1 emphasizes the possible 
differences between the two strains at a sequence level, aside from the mutations that are already 
known.  And while three of the four differences discovered within the algX sequence did not 
result in a difference at the amino acid level, it has been demonstrated that even silent mutations 
can have a significant effect on transcription and translation [61]. 
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Transcriptional Analysis of the Alginate Biosynthesis Operon 
 
Effect of culture media on acetylation of alginate produced by FRD1 
 Previous studies on both P. aeruginosa and the alginate-producing soil bacterium 
Azotobacter vinelandii have shown that levels of alginate acetylation in an individual strain can 
be influenced by changes in culture media.  For A. vinelandii, the addition of the buffering agent  
3-(N-morpholino)-propane-sulfonic acid (MOPS) to the growth culture at a concentration of 13.6 
mM increased the amount of alginate acetylation two-fold over that for the same strain cultured 
without the addition of MOPS.  The mean molecular masses and guluronate to mannuronate 
ratios for the alginate isolated from these cultures remained the same [62].  In work by Marty et 
al. [63], alginates produced by a mucoid P. aeruginosa strain isolated from a cystic fibrosis 
patient grown on solid nutrient media of various types were analyzed.  The alginate isolated from 
this mucoid strain grown on Modified Alginate Promoting (M.A.P.) media showed an increased 
level of acetylation when compared to the acetylation level of the alginate isolated from the same 
strain grown on MacConkey media.  There was no statistically significant change in the percent 
of alginate produced by the strain when grown on the different media or in the guluronate to 
mannuronate ratio [63].  While these findings demonstrated an ability to alter the level of 
alginate acetylation, the mechanism by which it is accomplished was not further investigated. 
 To determine whether similar growth conditions would influence the acetylation levels of 
the mucoid P. aeruginosa strain FRD1, uronic acid and acetylation amounts were measured for 
alginates produced from the strain when grown in culture media supplemented with MOPS, and 
when grown in M.A.P. and MacConkey broths.  As the work by Pena showed that the percent of 
alginate acetylation increased with increasing concentrations of MOPS (0 mM to 13.6 mM), the 
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highest concentration was selected for use in the analysis of FRD1 alginates [62].  Alginate was 
isolated by ethanol precipitation from FRD1 cultures grown overnight in Luria-Bertani media 
and Luria-Bertani media supplemented with MOPS to a concentration of 13.6 mM.   Uronic acid 
assays for alginate quantitation were performed using a method based on that of Dische [55] and 
acetylation amounts (microgram of acetyl group per milligram of uronic acid) were determined 
according to the method described by Hestrin [56].  The assays showed that while the total 
amount of uronic acid produced was significantly reduced for FRD1 grown in media containing 
MOPS (Figure 12), the acetylation level of the alginate produced was significantly increased by 
the addition of MOPS to the culture media (Figure 13).  This increase in alginate acetylation was 
similar to that seen in the A. vinelandii strain. 
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Figure 12.  Levels of uronic acids produced by P. aeruginosa strain FRD1 when grown in 
un-supplemented Luria-Bertani culture media and in Luria-Bertani media  supplemented 
with 13.6 mM 3-(N-morpholino)-propane-sulfonic acid (MOPS).  Data are shown as mean 
and standard deviation for two separate experiments with triplicates.  Asterisk represents a 
significant decrease in micrograms uronic acid per milligram of cell pellet produced by FRD1 
when grown in Luria-Bertani media supplemented with MOPS (P < 0.001, as determined by 
Student’s t-Test). 
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Figure 13.  Levels of acetylation of uronic acids produced by P. aeruginosa strain FRD1 
when grown in un-supplemented Luria-Bertani culture media and in Luria-Bertani media  
supplemented with 13.6 mM 3-(N-morpholino)-propane-sulfonic acid (MOPS).  Data are 
shown as mean and standard deviation for two separate experiments with triplicates.  Asterisk 
represents a significant increase in acetyl groups per milligram of uronic acids for alginate 
produced by FRD1 when grown in Luria-Bertani media supplemented with MOPS (P < 0.001, as 
determined by Student’s t-Test). 
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 To assess the effect on alginate acetylation of growth of P. aeruginosa FRD1 in different 
nutrient media, bacterial cultures were grown overnight in Modified Alginate Promoting 
(M.A.P.) broth and MacConkey broth.  Alginates were isolated by ethanol precipitation and 
uronic acid (Figure 14) and acetylation levels (Figure 15) were measured by the methods 
referenced earlier.  In accordance with the data presented by Marty et al. [63], the alginate 
produced by P. aeruginosa FRD1 grown in M.A.P. media was significantly more acetylated than 
that produced by the same strain grown in MacConkey media (Figure 15).  There was no 
significant difference in the levels of alginate produced by the strain when grown in MacConkey 
and M.A.P. media (Figure 14). 
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Figure 14.  Levels of uronic acids produced by P. aeruginosa strain FRD1 when grown in 
MacConkey and Modified Alginate Producing (M.A.P.) culture media.  Data are shown as 
mean and standard deviation for three separate experiments.  There was no significant change in 
levels of uronic acids produced by FRD1 when grown in MacConkey or M.A.P. media (P < 
0.001, as determined by Student’s t-Test). 
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Figure 15.  Levels of acetylation of uronic acids produced by P. aeruginosa strain FRD1 
when grown in MacConkey and Modified Alginate Promoting (M.A.P.) culture media.  
Data are shown as mean and standard deviation for three separate experiments.  Asterisk 
represents a significant increase in acetyl groups per milligram of uronic acids for alginate 
produced by FRD1 when grown in M.A.P. media (P < 0.001, as determined by Student’s t-Test). 
 
  
91 
 
 
 
 
  
0
0.05
0.1
0.15
0.2
0.25
MacConkey MAP
u
g
 A
c
e
ty
l G
ro
u
p
/m
g
 U
ro
n
ic
 A
c
id
Growth Media Types
FRD1
P<0.001
* 
92 
 
Sequence analysis of upstream regions of alginate biosynthesis genes 
 Having demonstrated the ability of the P. aeruginosa FRD1 strain to vary the level of 
alginate acetylation in response to growth media, experiments were undertaken to investigate a 
possible transcriptional basis for this finding.  Given the similarities between the A. vinelandii 
alginate biosynthesis operon and that of P. aeruginosa, and the presence of promoters upstream 
of the A. vinelandii algG and algA genes [44], a sequence analysis of the upstream regions of 
select P. aeruginosa alginate biosynthesis genes was done.  Upstream regions for algG, algX, 
algL, algI, algJ, algF, and algA were analyzed using BPROM analysis software, a sigma 70 
bacterial promoter recognition program [64].  For genes where the upstream intergenic region 
was larger than 100 base pairs, the entire intergenic region was analyzed.  For genes with smaller 
upstream intergenic regions, a 100 bp upstream region was analyzed, possibly containing the 
downstream region of the preceding gene.  Upon analysis, none of the upstream regions 
reviewed produced any potential sigma 70 binding sites.  The sequences of these same upstream 
regions were then manually scanned for possible consensus sequences for sigma factors E (AlgU 
or AlgT) and 54 (RpoN), both have which been shown to be involved in the regulation of 
alginate production [41].  This sequence scan produced a potential consensus match for σ
54
 in the 
upstream region of the algX biosynthesis gene (Figure 16). 
 
 
  
93 
 
Figure 16.   Upstream region (100 nt) of P. aeruginosa alginate biosynthesis gene algX with 
potential -12 and -24 consensus regions highlighted in gray.  The regions are a match for the -
12 and -24 regions recognized by σ
54 
[-24(GGA)/-12(GC)].  The algX start codon is indicated by 
a gray box. 
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--------GACCAGATCCTCGACCTGCTGGTGCGCCAGGACAAGGCGGTGCTGATCGACCCCGTGGAA 
AGCCAGGCCGAACTCCAGGACTGAGGACCCAGACGCATG-------- 
Potential -12 and -24 consensus regions 
P. aeruginosa algX start codon 
 
-24 -12 
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 While the work by Vazquez which identified the presence of a promoter upstream of the 
A. vinelandii algG alginate biosynthesis gene and the corresponding mRNA start site did not 
identify a consensus sequence match to any known promoters, the approximate -10 and -35 
regions were found to match those of the A. vinelandii algR promoter region [44].  An alignment 
of the A. vinelandii and P. aeruginosa algG upstream regions identified a similar consensus 
sequence upstream of the P. aeruginosa algG gene within the coding region of algE (Figure 17). 
 Further investigation into the other biosynthesis gene upstream regions identified a 
similar consensus sequence upstream of the P. aeruginosa algI biosynthesis gene (Figure 18). 
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Figure 17.  Sequence alignment of the upstream regions of the alginate biosynthesis gene 
algG from P. aeruginosa and A. vinelandii.  Consensus in the -10 and -35 regions is 
highlighted in light gray and asterisks indicate exact nucleotide matches.  Alignment was done 
using ClustalW [65]. 
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algE stop codon for P. aeruginosa algG start codon for P. aeruginosa 
and A. vinelandii 
-10 
-35 
A. vinelandii mRNA start site 
* ************* **  **           ***   * ** ***** 
* ************* **  ** 
* ************* **  ** 
A. vinelandii 
A. vinelandii 
P. aeruginosa 
P. aeruginosa 
 
 
AZOTO    ----------------------------------------TGCACCGTGTCTTCGTCGAC 
PSEUDO   AAGCCGGGCGACGCCTACGGGCCGGGCACCGACTCGACCATGCACCGCGCCTTCGTCGAC 
                                                  ******* * ********** 
 
AZOTO    ATGATCTGGCGCTTCTAAGGTCCAGCGGCACGCTGAGAGGATCGAACATGAACGTGCAAA 
PSEUDO   TTCATCTGGCGCTTCTGAGCCCCG---------CGAGGAAACCGGACATG---------- 
           * ************* **  **           ***   * ** *****           
98 
 
Figure 18.  Upstream region (240 nt) of P. aeruginosa alginate biosynthesis gene algI with 
potential -10 and -35 consensus regions highlighted in gray.  The regions are a partial match 
for the -10 and -35 regions found within the A. vinelandii algR promoter.  The algI start codon is 
indicated by a gray box. 
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--------GGCGTGGCGGGAAGCGGGCGCACAGGCCGGGGGCCACGCGCCCCTCTACCCCGCTCGCCGACCAGGCGT 
CCCACCAGGCGCCACACCCCGACCCATGCGCGACAGACGCGGGCGGGCGCAACACCTTAGGCAACACCACGGGGAGG
AAAACGGCGGGTCGTCCCGCCTTTCCTCGAGCGCTCCAGGGCGCGGAAAGGCAGGGCCGACCTGAATGGTTGACGCT
CTAGAGAGAGAGACGGCATG-------- 
-35 -10 
P. aeruginosa algI start codon 
Potential -10 and -35 consensus regions 
DNA sequence at -10 and -35 of A. vinelandii algR promoter region – CCGTGN23-CGCT 
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Demonstration of promoter activity in regions upstream of algG and algI alginate 
biosynthesis genes 
 To further investigate transcriptional activity within the alginate biosynthesis operon and 
assess potential promoter activity, beta-galactosidase assays were performed with the upstream 
regions of several genes within the operon.  LacZ fusion plasmids were constructed using 
plasmid pSS269 (medium copy vector) containing the upstream regions of algG, algX, algI, algJ 
and algF and conjugated into P. aeruginosa strain FRD1 (Figure 19). 
 The beta-galactosidase activity induced by these upstream regions was compared to 
baseline endogenous activity in the P. aeruginosa FRD1 strain.  In addition, the activity of the 
PalgD promoter was assayed as a positive control for the experiment and for comparative value.  
Of the regions assayed, algG and algI were found to possess significant activity while algX, algJ, 
and algF did not.  The strain containing the upstream region of algG demonstrated 
approximately 30% of the activity possessed by the strain containing the upstream region of algI, 
with both expressing significantly less activity than the PalgD control strain.  Activity measured 
for the strains containing the upstream regions of algX, algJ, and algF was at or below the 
baseline level for the FRD1 strain (Table 7). 
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Figure 19.  Schematic representation of alginate biosynthesis gene upstream regions and 
lacZ reporter plasmid pSS269 listing the strain generated by each fusion.  Overhangs 
generated by annealing of complimentary single-stranded oligonucleotides or by digestion of 
PCR product with restriction enzymes are shown.  Stabilizing fragment (S.F.) is required for 
replication of the plasmid in P. aeruginosa and oriT is required for conjugation into 
Pseudomonas.  
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Table 7.  Beta-galactosidase activity of lacZ fusion contructs containing upstream regions of 
alginate biosynthesis genes in FRD1 
Strain Region 
Miller Units 
(Average) Activity 
Significanta 
(P<0.001) 
FRD1 N/A 14.2 ± 2.1 No No 
JLP173 algG upstream 53.9 ± 10.2 Yes Yes 
JLP184 algX upstream 4.6 ± 4.4 No No 
JLP176 algI upstream 195.9 ± 28.4 Yes Yes 
JLP179 algJ upstream 12.8 ± 3.2 No No 
JLP182 algF upstream 4.9 ± 3.3 No No 
JLP196 PalgD 84083 ± 17536.8 Yes Yes 
     
a 
Represents a significant increase in beta-galactosidase activity as compared to the FRD1 strain. 
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Attempted identification of mRNA start sites in regions upstream of algG and algI alginate 
biosynthesis genes 
 In an effort to determine mRNA start sites for the promoters identified through the beta-
galactosidase assay, 5’ RACE was attempted for the upstream regions of the algG and algI 
alginate biosynthesis genes.  Using the SMARTer™ Race kit by Clontech, 5’ RACE ready 
cDNA containing modified 5’ ends was generated for each upstream region using gene specific 
primers.  Successful generation of the cDNA was confirmed by amplification of prepared control 
cDNA using test primers included in the kit, and successful binding of the gene specific primers 
was confirmed by amplification of cDNA fragments using both the forward and reverse real-time 
primers for each gene.  Multiple attempts at PCR amplification of cDNA fragments containing 
the 5’ end, however, proved unsuccessful.  A product of approximately 500 bp was amplified 
from the algI cDNA during a PCR reaction designed to amplify transcript originating from the 
algD promoter, but cloning and subsequent sequencing did not yield sequence matching the 
upstream region of algI. 
 
Evaluation of relative transcript levels of alginate biosynthesis genes from FRD1 grown in 
Luria-Bertani, MacConkey and Modified Alginate Promoting media 
 To gather further information about the mechanism by which alginate acetylation levels 
are modified within P. aeruginosa, real-time PCR was performed to evaluate transcript levels of 
select genes within the biosynthesis operon.  Transcript levels of algD, algG, algI and algA 
produced from P. aeruginosa strain FRD1 were measured when grown under similar conditions 
but in different media types.  Transcript levels of oprF, an outer membrane protein, were also 
measured and used for normalization.  MacConkey and Modified Alginate Promoting media 
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(M.A.P.) were used since FRD1 grown in these media types was shown previously to produce 
alginate with different levels of acetylation (this study).  Transcript levels from P. aeruginosa 
FRD1 grown in Luria-Bertani were also measured as this is often the standard culture media.   
 RNA was isolated from FRD1 cultures grown in the various media types as outlined in 
the Materials and Methods section and relative transcript levels were obtained by quantitative 
real-time PCR.  Under typical growth conditions in Luria-Bertani media, normalized transcript 
levels of algG, approximately 5.8 kb downstream of algD, decreased sharply compared to algD.  
Interestingly, normalized transcript levels of algI, approximately 10.2 kb downstream of algD 
and 2.8 kb downstream of algG, were measured at levels below those of algD, but significantly 
above those of algG.   Normalized transcript levels of algA, 2.1 kb downstream of algI, were 
decreased from levels of algI, but significantly above those of algG (Figure 20). 
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Figure 20.  Normalized transcript levels of alginate biosynthesis genes in P. aeruginosa 
strain FRD1 grown in Luria-Bertani media.  Data are shown as mean and standard deviation 
for two separate experiments carried out with technical triplicates.   
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 Compared to relative transcript levels from P. aeruginosa grown in MacConkey media, 
transcript levels were significantly increased for all studied genes from P. aeruginosa grown in 
M.A.P. media, with the exception of algG.  As in FRD1 cultures grown in Luria-Bertani media, 
transcript levels of algG were significantly decreased compared to other studied genes within the 
alginate biosynthesis operon and levels were not significantly different between growth in 
MacConkey and M.A.P. media types.  Unlike transcript levels for algA from P. aeruginosa 
grown in Luria-Bertani or MacConkey media, transcript levels of algA tended to increase over 
levels of algI from P. aeruginosa grown in M.A.P. media (Figure 21).  The fold increase of 
transcript levels measured from FRD1 M.A.P. cultures over those measured from MacConkey 
cultures was similar for algD and algI, and somewhat less for algG.  The fold increase in algA 
transcript levels was the highest of the four studied biosynthesis genes (Table 8). 
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Table 8.  Fold increase in normalized transcript levels of alginate 
biosynthesis genes in P. aeruginosa strain FRD1 grown in M.A.P. media 
over those grown in MacConkey media 
  
Gene Fold Difference 
algD 1.7 
algG 1.4 
algI 1.8 
algA 2.5 
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Figure 21.  Normalized transcript levels of alginate biosynthesis genes in P. aeruginosa 
strain FRD1 grown in MacConkey media and Modified Alginate Promoting (M.A.P.) 
media.  Data are shown as mean and standard deviation of a representative experiment carried 
out with technical triplicates.  Asterisks represent a significant increase in gene transcript 
amounts in FRD1 grown in M.A.P. media over those in FRD1 grown in MacConkey media (P < 
0.01, as determined by Student’s t-Test). 
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Discussion 
 The data presented here clearly identify the presence of two previously unknown 
promoters within the alginate biosynthesis gene cluster.  The results of the beta-galactosidase 
assays indicate one promoter within the region 100 nucleotides upstream of the algG gene, 
possibly within the algE coding region, and another within the 250 nt region upstream of the algI 
coding region (Table 7).  In the mucoid P. aeruginosa FRD1 strain under typical laboratory 
growth conditions, the activity of the promoter upstream of the algI gene as measured by the 
level of enzyme activity from the reporter fusion plasmid appears approximately 60% more 
active than the promoter upstream of the algG gene.  While in both cases sequence scans of the 
promoter-containing regions did not reveal a sequence match to any known promoter consensus 
sequence, both regions did contain sequence similar to that found at the -10 and -35 regions of 
the promoter region of the A. vinelandii algR gene (Figures 17 and 18).  This sequence is also 
found in the -10 and -35 regions of the previously identified promoter upstream of the algG gene 
in A. vinelandii (Figure 15).  Further analysis also identified an exact match for this sequence in 
the promoter region of the P. aeruginosa algR gene (Figure 22).  As transcription of the A. 
vinelandii algR gene is not regulated by sigma 22 (AlgU/AlgT) or AlgR as it is in P. aeruginosa, 
both algR and algG in A. vinelandii are believed to be regulated by a sigma factor that has not 
yet been identified [44, 66].  It is possible that a similar unidentified sigma factor may be 
responsible for transcription from these newly identified promoters upstream of the algG and 
algI alginate biosynthesis genes in P. aeruginosa.  Previous work has shown that a transposon 
insertion into the algD gene, the first gene in the alginate biosynthesis gene cluster, has a polar 
effect on downstream genes to the extent that a non-mucoid phenotype results and transcription 
of downstream genes, including algA, is reduced [51].  While this would indicate that any 
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promoters present within the alginate biosynthesis gene cluster lack sufficient activity to produce 
a mucoid phenotype on their own, it does not rule out the possibility that other promoters within 
the cluster may exist and possess sufficient activity to alter polymer characteristics. 
 A model of the alginate biosynthesis operon illustrating the newly discovered promoter 
sites is shown in Figure 23. 
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Figure 22.  Upstream region (130 nt) of P. aeruginosa alginate biosynthesis transcriptional 
regulator gene algR with key areas indicated.  Underlined sequence is similar to sigma E 
(AlgU/AlgT/RpoE/sigma 22) promoter consensus sequence and overlined sequence matches 
sigma 54 promoter consensus sequence.  Gray shaded sequence matches -10 and -35 region 
sequence of algR from A. vinelandii.  The mRNA start site (+1), the putative ribosome-binding 
site, and the algR start codon are indicated. 
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-----CACAATATCGATGCACGACTTGGGGCACTTTTCGGGCCTAAAGCGAGTCTCAGCGTCGAGCGCCGTGACGGA 
CGGCACTACACCTGTCTACGCTATCCATGTGCGCGACTCATGCAGGAAGCCTGAGCTTATGAATGTCCT----- 
+1 
P. aeruginosa algR start codon 
Putative RBS 
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Figure 23.  Model of P. aeruginosa alginate biosynthesis operon showing the PalgG and PalgI 
promoter sites.   
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 The promoter identified upstream of algI in this work may function in this manner, 
contributing to the increase in transcript levels of algI and the downstream algA gene for P. 
aeruginosa FRD1 grown in M.A.P. media demonstrated by the qRT-PCR results (Figure 19).  As 
hypothesized, levels of algI transcript from FRD1 grown in M.A.P. media were increased over 
levels of algI transcript from FRD1 grown in MacConkey media.  However, the increase in 
transcript level of algI was not sufficient when compared to the increased transcript level of algD 
to rule out transcription from the algD promoter as the cause for the increased level of algI 
transcript.  Growth in M.A.P. media is known to increase the level of alginate production of 
mucoid P. aeruginosa strains [67], and while the increase in algD transcription was expected, the 
decreased level of transcript from the algG gene upstream of algI complicates the comparison of 
transcript levels between algI and algD.  Of note, however, is the observation that the transcript 
level of the algA gene was increased over the transcript level of algI for FRD1 grown in M.A.P. 
media, but not for FRD1 grown in either Luria-Bertani or MacConkey media, lending support to 
the hypothesis of differential regulation (Table 8).  It is not known whether the effect of 
increased alginate acetylation for strains grown in M.A.P media or with the addition of MOPS to 
the growth media is due to the chemical composition of the media or possibly an increased 
buffering capacity. 
 Another significant finding of this work resulted from the quantitative real-time PCR 
analysis of select alginate biosynthesis genes.   Data showed that regardless of the growth media, 
transcript levels of the FRD1 algG gene were significantly less than transcript levels of the algD 
and algI genes (Figures 20 and 21).  As the algG gene is located approximately 5.8 kb 
downstream of the PalgD promoter, it is not surprising that transcription of the gene may be 
affected by ‘natural polarity’ as is the case for some other genes located distal to the promoter in 
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large operons [68].  The relative increase in transcript levels of algI compared to algG may be 
attributed to transcription from yet unidentified sigma 22 binding sites downstream of algG, 
transcription from the promoter upstream of algI identified in this work, or some combination of 
these mechanisms.  
 From a functional standpoint, the reduced level of algG transcripts demonstrated by the 
quantitative real-time PCR analysis is not surprising.  In both P. aeruginosa and A. vinelandii the 
algG gene encodes a C-5 epimerase for epimerization of mannuronates into guluronates.  
However, A. vinelandii also possesses an additional seven extracellular epimerases that can 
generate different patterns of mannuronates and guluronates in the alginate polymer, as well as 
blocks of guluronates of varying length [69].  These additional epimerases in A. vinelandii are 
necessary to generate a polymer containing sufficient guluronates for the cyst formation 
characteristic of the bacteria.  An engineered strain of A. vinelandii possessing only the 
epimerase encoded by the algG gene, produced an alginate polymer consisting of only 2% 
guluronate residues where the wild-type strain produced a polymer of 25% guluronnate [70].  As 
P. aeruginosa does not undergo an encystment process and does not possess any additional 
mannuronate epimerases, the level of mannuronate epimerization generated by the algG gene 
product is evidently sufficient for the bacteria’s needs [71].  In addition, the algL gene in P. 
aeruginosa, found downstream of algG and upstream of algI, encodes an alginate lyase which 
has been shown to be deleterious to the alginate produced by strains overexpressing this gene 
product [72]. 
 Further transcriptional studies would be extremely helpful in formulating a hypothesis 
regarding transcriptional activity and possible differential regulation within the biosynthesis 
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operon.  Quantitative RT-PCR on the remaining biosynthesis genes would provide additional 
clarification as would beta-galactosidase assays.   
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Involvement of Disulfide Bonding in AlgF Protein Interactions 
 
Generation of recombinant AlgF protein and detection of interacting proteins 
 As much of the genetic analysis on the P. aeruginosa alginate biosynthesis operon 
supports the hypothesis of a scaffolding complex necessary for the production of alginate 
polymer, an investigation into protein interactions involving the acetylation protein AlgF was 
initiated.  To facilitate this analysis, a strategy for the construction, expression, and purification 
of a Strep-II tagged AlgF recombinant protein was developed.  The Strep-tag II/Strep-Tactin 
system had previously been used successfully in protein co-purification experiments involving 
another alginate biosynthesis protein, AlgX, and was selected for use in this analysis [73]. 
 The pASK-IBA63b vector was purchased from IBA GmbH (Goettingen, Germany) and 
modified for use in P. aeruginosa as illustrated in Figure 24 and as outlined in the Materials and 
Methods section.  The coding sequence of algF from P. aeruginosa strain FRD1 was inserted 
into the multiple cloning site (MCS) of the modified vector and the resulting plasmid was 
conjugated into the ΔalgF strain FRD1175 resulting in strain JLP113. 
 Growth curves of the three P. aeruginosa strains FRD1, FRD1175, and JLP113 were 
generated to determine if expression of the Strep-II tagged AlgF protein in JLP113 negatively 
affected the strain’s growth (Figure 25).  In conjunction with the time points of the growth 
curves, cell lysates were collected and subjected to SDS-PAGE and immunoblotting (Figure 26). 
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Figure 24.  Schematic representation of commercial C-terminal Strep-II tag® vector 
pASK-IBA63b altered for use in P. aeruginosa.  Pseudomonas oriT was incorporated into an 
SpeI restriction site to allow for conjugation into P. aeruginosa and mSF was incorporated at an 
NaeI site to allow for replication in Pseudomonas. 
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Figure 25.  Growth curves of P. aeruginosa strains FRD1 (CF isolate), FRD1175 
(FRD1ΔalgF), and JLP113 (FRD1175 with AlgF-Strep-II tag).  Strains were grown in Luria-
Bertani broth with shaking at 37°C.  Data are shown as mean and standard deviation for three 
separate experiments. 
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Figure 26.  Immunoblot showing AlgF expression in FRD1, FRD1175, and JLP113 across a 
time course.  Whole cell lysate from each strain was screened using α-AlgF antibody.  
Expression of AlgF in FRD1 increases somewhat over time while expression of recombinant 
AlgF in JLP113 decreases with time after induction.  Amount of protein per lane was 
standardized to total protein for each time point. 
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 Similarities of the growth curves indicated that the expression of the tagged AlgF protein 
in P. aeruginosa algF deletion strain JLP113 did not have a deleterious effect on the growth of 
the bacteria.  The immunoblot of cell lysates collected over the growth course showed that in the 
FRD1 strain levels of wild-type AlgF increased over time in relation to total protein.  Expression 
of the plasmid-encoded Strep-II tagged AlgF in JLP113 appeared to follow an opposite pattern 
with the amount of AlgF protein decreasing with the progression of time.  As expected, strain 
FRD1175 did not produce any AlgF over the time course. 
 To determine whether the AlgF Strep-II tagged protein was able to complement the algF 
deletion mutant in regard to alginate acetylation, alginate was isolated from each of the strains 
and the uronic acid and acetyl group content was determined.  As indicated by the results of the 
uronic acid assay, there was no significant difference in the amount of alginate produced by the 
strains (Figure 27).  Results of the acetylation assay indicated that the level of acetylation for the 
alginate produced by the strain complemented with the AlgF-tagged protein was significantly 
below that of the alginate produced by the FRD1 strain.  Even at this reduced level, however, 
acetylation levels in the complemented strain were still increased significantly over background 
levels indicating at least a minimal level of restoration of acetylation (Figure 28). 
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Figure 27.  Levels of uronic acid produced by P. aeruginosa strains FRD1, FRD1175, and 
JLP113.  Data are shown as mean and standard deviation of three separate experiments.  There 
was no significant difference between the strains in amount of alginate produced (P < 0.001, as 
determined by Student’s t-Test). 
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Figure 28.  Levels of acetylation of uronic acids produced by P. aeruginosa strains FRD1, 
FRD1175, and JLP113.  Data are shown as mean and standard deviation for three separate 
experiments.  While significantly decreased from the amount of acetyl groups per milligram of 
uronic acids for alginate produced by strain FRD1, levels of alginate acetylation in strain JLP113 
were significantly increased over background (FRD1175) (P < 0.001, as determined by Student’s 
t-Test). 
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 Strep-II tagged AlgF was purified from P. aeruginosa by gravity-flow column 
chromatography as outlined in the Materials and Methods section.  Upon subjecting the eluted 
protein to fractionation by SDS-PAGE under non-reducing conditions and without heating of the 
sample, higher molecular weight species could be visualized by immunoblotting.  These reactive 
bands at approximately 50 kDa and 33 kDa were eliminated when the protein sample was 
subjected to SDS-PAGE under reducing conditions and after boiling (Figure 29 A. and B.) 
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Figure 29 A and B.  Immunoblot of affinity purified AlgF subjected to SDS-PAGE under 
reducing and non-reducing conditions.  A.  Immunoblot of affinity purified AlgF subjected to 
SDS-PAGE under non-reducing conditions and without boiling shows higher molecular weight 
complexes between 50 - 37 kDA and 37 – 25 kDa. B. Upon boiling and addition of a reducing 
agent higher molecular weight complexes are disrupted.  Western blots were screened with a 
monoclonal α-Strep-tag II antibody and are representative of multiple experiments. 
 
 
  
135 
 
 
 
 
  
75 -
25 -
50 -
37 -
15 -
kDa
10 -
20 -
75 -
25 -
50 -
37 -
15 -
kDa
10 -
20 -
kDaA. B.
SDS, no reducing agent – 
sample not boiled 
SDS, reducing agent – 
sample boiled 5 minutes 
136 
 
 In an attempt to determine the nature of these higher molecular weight complexes, the 
purified AlgF protein was separated by 2-D Redox SDS-PAGE and silver stained (Figure 30).  
The protein eluate was fractionated in the first dimension under non-reducing conditions and 
without boiling, and then under reducing conditions in the second dimension.  This format results 
in individual proteins running on the diagonal, and proteins that possessed either intermolecular 
or intramolecular disulfide bonds falling to either side of the diagonal.  In the case of purified 
AlgF subjected to 2-D Redox SDS-PAGE, a protein from the first dimension that possessed 
intramolecular disulfide bonds can be seen to the left of the diagonal between approximately 15 
and 20 kDa.  The protein runs more slowly after disruption of the disulfide bond potentially due 
to the loss of tertiary structure.  The higher molecular weight complexes visible in the first 
dimension are circled along with their potential corresponding proteins in the second dimension.  
Proteins falling to this side of the diagonal represent proteins predicted to be involved in 
intermolecular disulfide bonding.  While complexed together in the first dimension, disruption of 
disulfide bonds under reducing conditions allows proteins to run at their individual, lower 
molecular weights.  The complexes do not appear to be oligomers of AlgF as the proteins are 
falling either above or below the molecular weight of AlgF in the second dimension.  AlgF or 
variants would fall along the horizontal line highlighted by the arrow.  To confirm that the 
proteins from the complexes were not AlgF, an identical 2-D Redox SDS-GEL was transferred 
to PVDF and screened with α-Strep antibody.  Only the AlgF protein spot indicated by the arrow 
on the silver-stained gel was detected by the antibody, indicating that the other proteins were not 
AlgF (data not shown). 
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Figure 30.  Affinity purified AlgF subjected to 2-D Redox SDS-PAGE.  Silver-stained 2-D 
Redox SDS-PAGE of affinity purified AlgF shows AlgF and co-purified proteins involved in 
both intramolecular and intermolecular interactions. 
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 To identify the highlighted interacting proteins, protein spots were excised and subjected 
to mass spectrometry analysis.  To increase the protein available for analysis, multiple gels were 
run and protein spots were pooled as outlined in the Materials and Methods section.  
Unfortunately, mass spectrometry analysis did not yield any peptide sequences matching 
Pseudomonas proteins.  This was likely due to insufficient amounts of the interacting proteins. 
 
Construction of AlgF site-directed mutant 
 As mass spectrometry analysis was unable to identify the interacting proteins visualized 
by 2-D Redox SDS-PAGE of affinity purified AlgF, a strategy was devised to mutate the 
cysteine residue in AlgF to a serine residue in the P. aeruginosa FRD1 genome.  This would 
allow for analysis of the alginate produced by the strain and a definitive determination as to the 
importance of the cysteine residue to AlgF function.  Serine was chosen for the substitution 
because its basic structure is similar to that of cysteine but contains a hydroxyl in place of the 
sulfhydryl.  This change would abolish any possibility for intermolecular protein interactions 
based on disulfide bonds, but would not be likely to result in drastic structural changes in the 
protein. 
 As outlined in the Materials and Methods section, a non-replicative plasmid construct 
that would result in the desired amino acid changes upon integration into the P. aeruginosa 
FRD1 genome was successfully created.  Repeated attempts to obtain products of even a single 
crossover event, however, were not successful.  Even attempted conjugation into the P. 
aeruginosa PAO1 strain was unsuccessful, indicating that lack of sufficient homologous 
sequence was not the likely source of difficulty.  Efforts are ongoing to generate this mutant.   
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Discussion 
 The approach of expressing and purifying affinity-tagged P. aeruginosa alginate 
biosynthesis proteins from P. aeruginosa instead of E. coli was adopted in an effort to obtain the 
most biologically relevant data possible regarding protein interactions.  As there are currently no 
assays available to validate the activity of purified alginate acetylation proteins, allowing for 
protein processing and folding within the native environment would seem the mostly likely 
avenue for isolating functioning protein.  Co-purification experiments using this system would 
also be simplified as any accessory proteins required for binding would be available. 
 While solid phase overlay and dot blot experiments using Strep-II tagged AlgF did not 
result in the identification of any interacting proteins (data not shown), fractionation of purified 
tagged protein under reducing and non-reducing conditions indicated that some interaction was 
occurring.  In some cases, higher molecular weight complexes were even visible under reducing 
conditions as in Figure 25 in JLP113 at the 6 hour time point.  In this case, it is possible that the 
reducing capacity of the buffer was overwhelmed by the quantity of protein and was unable to 
disrupt all complex formation.  The results of the 2-D Redox SDS-PAGE experiments reinforced 
what was seen in the first dimension by allowing visualization of the possible interacting 
proteins.  The inability to identify the individual proteins by mass spectrometry because of their 
low abundance was an unfortunate result. 
 As a possible solution to the inability to get sufficient amounts of interacting proteins in 
the second dimension for mass spectrometry analysis, the periplasmic fraction of P. aeruginosa 
was isolated and screened with α-AlgF antibody.  While AlgF was detected in the periplasmic 
fraction, silver staining of an identical SDS-PAGE gel also detected numerous other proteins in 
the fraction.  Excision of an individual band on the SDS-PAGE gel corresponding to a reactive 
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band on the immunoblot would not have been possible due to multiple bands of similar intensity 
in the same area. 
 A surprising result in these studies was the low level of acetylation seen in the JLP113 
strain (algF deletion strain complemented with Strep-II tagged AlgF).  While acetylation was 
clearly taking place, it occurred at a much lower level than the FRD1 strain.  In the immunoblot 
in Figure 26, it appears that the tagged AlgF is running at a higher molecular weight than the 
wild-type.  While the Strep-II tag adds 1 kilodalton, the difference in migration appears more 
significant.  This could indicate that a significant portion of the tagged protein is not folding 
correctly or is perhaps retaining its signal sequence.  This could account for the low 
complementation seen in the JLP113 strain. 
 It is still likely, however, that the protein produced from this construct in P. aeruginosa 
would produce more viable binding partners than a construct produced in E. coli where there 
would be no way to determine any level of activity and folding and cleavage issues would likely 
be increased. 
 A possible avenue to improve the complementation of a tagged AlgF construct might be 
to engineer a construct which replaces the algF signal sequence with the algX signal sequence.  
As a Strep-II tagged construct has been shown to fully complement an algX deletion strain, 
indicating proper export to the periplasm and cleavage of the signal sequence, use of the algX 
signal sequence may improve results [15]. 
 Another possibility would be the use of a different affinity tag.  While protein recovery of 
a His-tagged AlgF construct was poor and complementation of acetylation was not to the levels 
of the Strep-II AlgF construct (data not shown), there are other affinity tags available that could 
be investigated. 
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Conclusions 
 The goal of this work was to garner new and relevant information regarding the 
mechanism of alginate acetylation in Pseudomonas aeruginosa.  The lack of acetylation of the 
small uronics produced by the alginate biosynthesis mutants in this study provides important data 
about where within the cell alginate acetylation occurs.  Since the data indicate that a uronic acid 
polymer of some specific size is required for acetylation to occur, this supports a localization of 
the acetylation process to the periplasm where polyuronic fragments would be present. 
 The site-directed mutation of a conserved histidine residue in AlgX did not result in 
abolition of alginate acetylation as it did in the alginate acetylation protein AlgJ.  While the 
mutation allowed the role of AlgX in the purported periplasmic scaffold complex to be 
maintained, the results of the uronic acid and acetylation assays suggested that algX is not 
involved in acetylation.  Future work regarding AlgX could include an additional mutation of a 
neighboring histidine residue to ensure that it is not compensating for the original mutation, and 
random mutagenesis of algX to look for interesting phenotypes. 
 AlgF-Strep-II tagged co-purification experiments and 2D-Redox SDS PAGE indicated 
the presence of three proteins that may interact with the alginate acetylation protein AlgF via 
disulfide bonding.  While adequate amounts of protein could not be isolated for identification by 
mass spectrometry, a site-directed mutation in the P. aeruginosa FRD1 chromosome of the lone 
cysteine residue in AlgF to a serine residue is being pursued.  This strategy will conclusively 
determine the necessity of this residue for alginate acetylation. 
 Transcriptional analysis of the alginate biosynthesis operon conducted in this work 
indicates the possibility for previously unknown regulation within the operon.  The ability to 
manipulate the level of alginate acetylation in P. aeruginosa strain FRD1 based on growth media 
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was accomplished by growth in Modified Alginate Promoting media and by the addition of 
MOPS to Luria-Bertani media.  This finding led to further investigation into the possible 
mechanism for this change.  Beta-galactosidase assays conducted on lacZ fusions to regions 
upstream of the algG and algI alginate biosynthesis genes resulted in the discovery of two 
previously unidentified promoter regions.  Examination of the nucleotide sequence in both of 
these promoter regions showed significant homology to the -10 and -35 regions of the 
Azotobacter vinelandii algR promoter.  Quantitative real-time PCR experiments demonstrated 
that transcript levels of the alginate biosynthesis genes are not consistent across the operon and 
that additional regulation within the operon may be necessary to ensure adequate transcription of 
all alginate biosynthesis genes.  This additional regulation would also provide a method for 
altering the acetylation and epimerization level of the alginate polymer as may be required by the 
bacteria under differing environmental conditions.  Future work regarding transcription of the 
alginate biosynthesis operon could include:  qRT-PCR on the remaining alginate biosynthesis 
genes, analysis of possible transcriptional stop sites within the operon, and truncation of the algI 
and algG upstream regions to determine areas required for promoter activity.  
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